{
  "meta": {
    "title": "Biochemistry_Test",
    "url": "https://brainandscalpel.vercel.app/biochemistry-test-e31fd3d3.html",
    "scrapedAt": "2025-11-30T12:44:35.163Z"
  },
  "questions": [
    {
      "text": "Which of the following statements are true regarding the regulation of cholesterol synthesis?<div class='question-desc-html'><ol>\n<li>Insulin and thyroxine decrease HMG CoA reductase activity.</li>\n<li>Cortisol and glucagon decrease HMG CoA reductase activity.</li>\n<li>Statins inhibit HMG CoA reductase.</li>\n<li>Cholesterol increases HMG CoA reductase activity.</li>\n<li>Cholesterol represses transcription of HMG CoA reductase mRNA.</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 3, and 5"
        },
        {
          "id": 2,
          "text": "2, 3, and 4"
        },
        {
          "id": 3,
          "text": "1, 2, and 4"
        },
        {
          "id": 4,
          "text": "2, 3, and 5"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Statements <strong>2</strong>,<strong> 3</strong>, and<strong> 5</strong> are true regarding the regulation of cholesterol synthesis.</p>\n<p><strong>HMG CoA reductase</strong> is the principal enzyme involved in the <strong>regulation</strong> of <strong>cholesterol synthesis</strong>.&nbsp;Cholesterol is synthesized from <strong>acetyl-CoA</strong> mainly in the liver and intestine. This process occurs in the endoplasmic reticulum and cytosol.</p>\n<div class=\"page\" title=\"Page 261\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>HMG-CoA reductase reduces<strong> HMG-CoA</strong>&nbsp;to <strong>mevalonate</strong> by NADPH in the pathway of cholesterol synthesis.&nbsp;This principal regulatory step is targeted by <strong>statins</strong>, which are drugs that efficiently lower cholesterol by <strong>inhibiting HMG-CoA reductase</strong>.</p>\n<p>Activity of HMG-CoA reductase is influenced by the following factors:</p>\n<ul>\n<li>By-products of the cholesterol synthesis pathway:&nbsp;<strong>Mevalonate</strong>, the immediate product of the reaction, and&nbsp;<strong>cholesterol</strong>,&nbsp;the main product of the pathway, <strong>inhibit</strong> enzyme activity. These metabolites also repress transcription of HMG-CoA reductase mRNA by inhibiting sterol regulatory element-bidning protein (SREBP) transcription factor.</li>\n<li>Hormones:<strong> Insulin</strong>&nbsp;and <strong>thyroid hormones</strong> <strong>increase</strong>&nbsp;enzyme activity, whereas <strong>glucagon</strong> or <strong>glucocorticoids</strong> decrease it.</li>\n<li>Posttranslational modifications:&nbsp;Phosphorylation&ndash;dephosphorylation reactions affect enzyme activity.&nbsp;<strong>AMP-activated protein kinase (AMPK)</strong> phosphorylates and <strong>inactivates</strong> the enzyme.</li>\n<li>Diurnal variation</li>\n</ul>\n</div>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/affadf70f6e14d269ed81f681a304e06x600x566.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7087eb4a999a413da1c7e7c4a3566407x510x692.PNG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Rate determining enzymes and their key regulators</h3><table>\n<tbody>\n<tr>\n<td>Enzyme and Pathway</td>\n<td>Regulating factors</td>\n</tr>\n<tr>\n<td>Phosphofructokinase (PFK-1), Glycolysis</td>\n<td>\n<p>AMP+, Fructose 2,6 bi-phosphate+</p>\n<p>ATP-, Citrate-</p>\n</td>\n</tr>\n<tr>\n<td>Fructose-1,6-bisphosphatase, gluconeogenesis</td>\n<td>\n<p>ATP+, Acetyl CoA+</p>\n<p>AMP-, Fructose 2,6 bi-phosphate-</p>\n</td>\n</tr>\n<tr>\n<td>Isocitrate dehydrogenase (Krebs cycle)</td>\n<td>\n<p>ADP+,</p>\n<p>ATP-, NADH-</p>\n</td>\n</tr>\n<tr>\n<td>Glycogen synthase, glycogenesis</td>\n<td>\n<p>Glucose-6-phosphate+, insulin+, cortisol+,</p>\n<p>Epinephrine-, glucagon-</p>\n</td>\n</tr>\n<tr>\n<td>Glycogen phosphorylase, glycogenolysis</td>\n<td>\n<p>Epinephrine+, glucagon+, AMP+</p>\n<p>Glucose-6-phosphate-, insulin-, ATP-</p>\n</td>\n</tr>\n<tr>\n<td>Glucose-6-phosphate dehydrogenase (G6PD), HMP shunt</td>\n<td>\n<p>NADP+</p>\n<p>NADPH-</p>\n</td>\n</tr>\n<tr>\n<td>Carbamoyl phosphate synthetase II, Denovo pyrimidine synthesis</td>\n<td>\n<p>ATP+</p>\n<p>UTP-</p>\n</td>\n</tr>\n<tr>\n<td>Glutamine-phosphoribosylpyrophosphate (PRPP) amidotransferase, denovo purine synthesis</td>\n<td>AMP-, IMP-, GMP-</td>\n</tr>\n<tr>\n<td>Carbamoyl phosphate synthetase I, Urea cycle</td>\n<td>N-acetyl glutamate (NAG)+</td>\n</tr>\n<tr>\n<td>Acetyl-CoA carboxylase (ACC), fatty acid synthesis</td>\n<td>\n<p>Insulin+, citrate+</p>\n<p>Glucagon-, palmitoyl-CoA-</p>\n</td>\n</tr>\n<tr>\n<td>Carnitine acyltransferase I, Fatty acid oxidation</td>\n<td>Malonyl-CoA-</td>\n</tr>\n<tr>\n<td>HMG-CoA reductase, cholesterol synthesis</td>\n<td>\n<p>Insulin+, thyroxine+</p>\n<p>Glucagon-, cholesterol-</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>+ Positive effect on the pathway.</p>\n<p>- Negative effect on the pathway.</p><hr><h3>Related Pearl: Sites of various pathways in cell</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Sites of metabolism</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Mitochondria</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Fatty acid oxidation (&beta;oxidation)</p>\n<p>Acetyl CoA production</p>\n<p>TCA Cycle</p>\n<p>Oxidative phosphorylation</p>\n<p>Ketogenesis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cytoplasm</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Glycolysis</p>\n<p>HMP Shunt</p>\n<p>Synthesis of steroids(SER)</p>\n<p>Proteins (RER and Ribosomes)</p>\n<p>Fatty acids</p>\n<p>Cholesterol</p>\n<p>Nucleotides</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Both</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Heme synthesis</p>\n<p>Urea cycle</p>\n<p>Gluconeogenesis</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Enzymes active in phosphorylated and dephosphorylated state</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Phosphorylated state</strong></p>\n<p>(Low insulin)</p>\n</td>\n<td>\n<p><strong>Dephosphorylated state</strong></p>\n<p>(High insulin)</p>\n</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Fructose 2,6 bisphosphatase</li>\n<li>PEP carboxykinase</li>\n<li>Pyruvate carboxylase</li>\n<li>Glycogen phosphorylase</li>\n<li>Hormone-sensitive lipase</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Phosphofructokinase</li>\n<li>Pyruvate dehydrogenase</li>\n<li>Glycogen synthase</li>\n<li>Acetyl CoA carboxylase</li>\n<li>HMG CoA reductase</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "FC0227",
      "difficulty": "hard"
    },
    {
      "text": "A patient with a history of using well water for cooking and consumption presents with vomiting and abdominal pain. On examination, there is jaundice, hemoglobinuria, Mees lines on the nails, and features of hypovolemic shock. A toxicology screen is done, and the 24-hour urine sample is found to contain high amounts of a toxin.  Which enzyme of Kreb's cycle will be inhibited by this toxin?",
      "choices": [
        {
          "id": 1,
          "text": "Glyceraldehyde 3-phosphate dehydrogenase"
        },
        {
          "id": 2,
          "text": "Alpha-ketoglutarate deydrogenase"
        },
        {
          "id": 3,
          "text": "Aconitase"
        },
        {
          "id": 4,
          "text": "Succinate dehydrogenase"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario is suggestive of <strong>arsenic toxicity</strong>. <strong>Alpha-ketoglutarate dehydrogenase&nbsp;(AKG)</strong> of Kreb's cycle is inhibited by this toxin, <strong>arsenite</strong> (inorganic arsenic salt).</p>\n<p><strong>&alpha;-Ketoglutarate </strong>is a rate-determining intermediate in Kreb's cycle. It&nbsp;has a crucial role in cellular energy metabolism as it acts as a precursor of glutamate and glutamine and promotes protein synthesis.</p>\n<p><strong>Alpha-ketoglutarate</strong>&nbsp;undergoes oxidative decarboxylation to form&nbsp;<strong>succinyl-CoA</strong> and CO<sub>2</sub>&nbsp;with the help of the multienzyme complex, <strong>AKG dehydrogenase</strong>. This enzyme complex requires the cofactors, thiamin diphosphate, lipoate, NAD+, flavin&nbsp;adenine dinucleotide (FAD), and coenzyme A.</p>\n<p><strong>Arsenite</strong> inhibits this decarboxylation reaction and causes the substrate, &alpha;-ketoglutarate, to accumulate.&nbsp;</p>\n<div class=\"page\" title=\"Page 6797\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Arsenic toxicity </strong>is either due to inhalation of toxic arsenic gas or chronic consumption of foods cooked in contaminated well water. It&nbsp;presents with malaise, headache, nausea, vomiting, abdominal pain, jaundice, hemoglobinuria, and renal failure. There may be <strong>hemorrhagic gastroenteritis, hypovolemic shock, and cardiovascular manifestations</strong> such as QT prolongation, polymorphous ventricular tachycardia, and congestive cardiomyopathy. <strong>Mees lines</strong>&nbsp;is a common dermatologic manifestation characterized by transverse white striae on the nail.</p>\n<p>Arsenic toxicity is detected by measuring the 24-hour urine excretion of arsenic.</p>\n</div>\n</div>\n</div>\n</div>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/37a8b2f16ea247a4b1be3539c7dc55f9x1280x4900.JPEG\" alt=\"Explanation Image\"><p>Other options:&nbsp;</p>\n<p>Option A:&nbsp;<strong>Glyceraldehyde 3-phosphate dehydrogenase&nbsp;</strong>is inhibited by <strong>iodoacetate</strong>. It is not a part of Kreb's cycle.</p>\n<p>Option C:&nbsp;<strong>Aconitase</strong> is inhibited by <strong>fluoroacetate</strong>.</p>\n<p>Option D: <strong>Succinate dehydrogenase</strong> is inhibited by <strong>malonate</strong>.</p><hr><h3>Related Pearl: Inhibitors of metabolic pathways</h3><p><strong>Inhibitors of glycolysis</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Agent</strong></td>\n<td><strong>Enzyme</strong></td>\n</tr>\n<tr>\n<td>Iodoacetate</td>\n<td>Glyceraldehyde 3-phosphate dehydrogenase</td>\n</tr>\n<tr>\n<td>Arsenate</td>\n<td>Phoshphoglycerate kinase</td>\n</tr>\n<tr>\n<td>Fluoride</td>\n<td>Enolase</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p><strong>Inhibitors of TCA cycle</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Agent</strong></td>\n<td><strong>Enzyme</strong></td>\n</tr>\n<tr>\n<td>Fluoroacetate</td>\n<td>Aconitase</td>\n</tr>\n<tr>\n<td>\n<div class=\"page\" title=\"Page 176\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Arsenite</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>&alpha;-ketoglutarate dehydrogenase</td>\n</tr>\n<tr>\n<td>Malonate</td>\n<td>Succinate dehydrogenase</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p><strong>Inhibitors of electron transport</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Complex</strong></td>\n<td><strong>Inhibitors</strong></td>\n</tr>\n<tr>\n<td>Complex I</td>\n<td>Piercidin, Amobarbital, Rotenone</td>\n</tr>\n<tr>\n<td>Complex II</td>\n<td>TTFA, Carboxin, Malonate</td>\n</tr>\n<tr>\n<td>Complex III</td>\n<td>BAL, Antimycin A</td>\n</tr>\n<tr>\n<td>Complex IV</td>\n<td>Hydrogen sulphide, Carbon monoxide, Cyanide</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p><strong>Inhibitors of oxidative phosphorylation</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Agent</strong></td>\n<td><strong>Mechanism</strong></td>\n</tr>\n<tr>\n<td>Atractyloside</td>\n<td>Inhibits ADP and ATP Transporter</td>\n</tr>\n<tr>\n<td>Oligomycin</td>\n<td>Blocks flow of protons through Fo complex</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Steps involved in TCA cycle</h3><table>\n<tbody>\n<tr>\n<td><strong>Step 1</strong></td>\n</tr>\n<tr>\n<td>\n<p>Acetyl CoA + Oxaloacetate &rarr; Citrate</p>\n<p>&nbsp; &nbsp; &nbsp;(2C &nbsp;+ 4C &nbsp;= &nbsp; 6C)</p>\n<p>Enzyme: Citrate Synthase</p>\n<p><strong>Irreversible</strong>, Exothermic reaction</p>\n</td>\n</tr>\n<tr>\n<td><strong>Step 2</strong></td>\n</tr>\n<tr>\n<td>\n<p>Citrate &rarr; Cis &ndash;aconitate&nbsp; &rarr; Isocitrate&nbsp;</p>\n<p>( 6C &nbsp; &nbsp;&rarr; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;6C &rarr; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 6C)</p>\n<p>Enzyme:&nbsp;&nbsp; <strong>Aconitase</strong></p>\n<p>Cofactor:&nbsp;&nbsp; Fe<sup>2+</sup></p>\n<p>The Reaction occurs in 2 steps: &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</p>\n<p>1<sup>st</sup> step:&nbsp; Dehydration&nbsp; &nbsp; &nbsp;&nbsp;</p>\n<p>2<sup>nd</sup> step:&nbsp; Rehydration</p>\n<p>Inhibited by:<strong> Fluoroacetate (Non- Competitive)</strong></p>\n</td>\n</tr>\n<tr>\n<td><strong>Step 3</strong></td>\n</tr>\n<tr>\n<td>\n<p>Isocitrate &rarr;[Oxalosuccinate]&rarr;&alpha;- Keto glutarate</p>\n<p>&nbsp; &nbsp; &nbsp; &nbsp; (6C) &rarr; &nbsp; &nbsp; &nbsp; &nbsp; [6C] &nbsp; &nbsp; &nbsp; &nbsp; &rarr; &nbsp; &nbsp; &nbsp; &nbsp; (<strong>5C</strong>)</p>\n<p>Enzyme:&nbsp; Isocitrate Dehydrogenase</p>\n<p>Cofactor:&nbsp;&nbsp; Mn<sup>2+ </sup>or Mg<sup>2+</sup></p>\n<p>Reaction: &nbsp;Oxidative &nbsp;Decarboxylation</p>\n<p><strong>Intermediate:&nbsp;&nbsp; Oxalosuccinate [ Unstable]</strong></p>\n<p>Release:&nbsp;&nbsp;&nbsp; 1 NADH and CO2</p>\n</td>\n</tr>\n<tr>\n<td><strong>Step 4</strong></td>\n</tr>\n<tr>\n<td>\n<p>&alpha;- Keto glutarate &rarr; Succcinyl Co A&nbsp;</p>\n<p>&nbsp; &nbsp; &nbsp; &nbsp;(5C &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &rarr; &nbsp; &nbsp; &nbsp; &nbsp; 4C)</p>\n<p>Enzyme: &alpha;- Ketoglutarate Dehydrogenase(Multienzyme complex)</p>\n<p>Reaction:&nbsp; Oxidative Decarboxylation</p>\n<p>Inhibited by: <strong>Arsenite&nbsp; (Non &ndash; Competitive)</strong></p>\n<p>Physiologically <strong>unidirectional</strong> step.</p>\n<p>Release: 1 NADH and CO2</p>\n</td>\n</tr>\n<tr>\n<td><strong>Step 5</strong></td>\n</tr>\n<tr>\n<td>\n<p>Succinyl- CoA&nbsp; &rarr; Succinate</p>\n<p>&nbsp; &nbsp; &nbsp; ( 4C &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&rarr; &nbsp; &nbsp; &nbsp; &nbsp; 4C )</p>\n<p>Enzyme<strong>:&nbsp; Succinate Thiokinase</strong></p>\n<p>Cofactor: Mg<sup>2+</sup></p>\n<p>Release:&nbsp; 1 ATP / GTP</p>\n<p><strong>Substrate level phosphorylation</strong></p>\n</td>\n</tr>\n<tr>\n<td><strong>Step 6</strong></td>\n</tr>\n<tr>\n<td>\n<p>Succinate&nbsp; &rarr;&nbsp;&nbsp; Fumarate</p>\n<p>( 4C &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&rarr; &nbsp; &nbsp; &nbsp; &nbsp; 4C )</p>\n<p>Enzyme:&nbsp; Succinate Dehydrogenase (Part of 2<sup>nd</sup> complex ETC)</p>\n<p>Cofactor:&nbsp; <strong>FAD and Fe-S protein</strong>&nbsp;</p>\n<p>The only enzyme of TCA cycle attached to the <strong>inner</strong> <strong>mitochondrial membrane.</strong></p>\n<p>Inhibited by:&nbsp;<strong>Malonate</strong>&nbsp;(<strong> competitive)</strong></p>\n<p>Release: FADH<sub>2</sub></p>\n</td>\n</tr>\n<tr>\n<td><strong>Step 7</strong></td>\n</tr>\n<tr>\n<td>\n<p>Fumarate&nbsp; &rarr;&nbsp;&nbsp; Malate</p>\n<p>( 4C &nbsp; &nbsp; &nbsp; &nbsp; &rarr; &nbsp; &nbsp; 4C )</p>\n<p>Enzyme:&nbsp; Fumarate Hydratase</p>\n<p>Reaction: Hydration</p>\n</td>\n</tr>\n<tr>\n<td><strong>Step 8</strong></td>\n</tr>\n<tr>\n<td>\n<p>Malate&nbsp; &rarr;&nbsp; Oxaloacetate &nbsp;</p>\n<p>( 4C &nbsp; &nbsp; &rarr; &nbsp; &nbsp; &nbsp; &nbsp;4C )</p>\n<p>Enzyme:&nbsp; Malate Dehydrogenase</p>\n<p>Release:&nbsp; 1 NADH</p>\n<p>Oxaloacetate<strong> is</strong> <strong>regenerated.</strong></p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/76825a8fa7b34db89430c4b5211dd573x1280x1018.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Arsenic poisoning</h3><p>Summary of Arsenic poisoning</p>\n<p><strong>Source of exposure: </strong>Arsenic-containing pesticides, natural sources - drinking water and soil</p>\n<p><strong>Route of absorption: </strong>GI tract</p>\n<p><strong>Mechanism of action:</strong> binds to sulfhydryl groups and inhibits pyruvate dehydrogenase, gluconeogenesis, glutathione metabolism</p>\n<p>Characteristic clinical findings are as follows: Mnemonic-ARSENIC</p>\n<p><strong>A</strong>- Aldrich mees lines</p>\n<p><strong>R</strong>- raindrop pigmentation, rash, red velvety mucosa</p>\n<p><strong>S</strong>- subendocardial haemorrhage</p>\n<p><strong>E</strong>- Excessive pigmentation- Blackfoot disease</p>\n<p><strong>N</strong>- Neuritis</p>\n<p><strong>I</strong>- Iron oxide + BAL –treatment</p>\n<p><strong>C</strong>- Cholera-like illness</p>\n<p><strong>Diagnosis:</strong> 24-hour urine arsenic</p>\n<p><strong>Treatment:</strong> <strong>BAL; succimer(DMSA)</strong></p>\n<p>Clinicopathological findings in acute and chronic arsenic poisoning:</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>System</strong></p>\n</td>\n<td>\n<p><strong>Acute</strong></p>\n</td>\n<td>\n<p><strong>Chronic</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Skin</p>\n</td>\n<td>\n<p>Delayed hair loss (alopecia)</p>\n</td>\n<td>\n<p>Melanosis, Bowen’s disease facial edema, hyperkeratosis, cutaneous cancer, hyperpigmentation.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Nails</p>\n</td>\n<td>\n<p>Mees’s lines in 2-3 weeks post ingestion.</p>\n</td>\n<td>\n<p><strong>Mees' lines</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Neurologic</p>\n</td>\n<td>\n<p>Hyperpyrexia, convulsions, tremors, coma</p>\n</td>\n<td>\n<p>Encephalopathy, polyneuropathy, tremors, axonal degeneration</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GI tract</p>\n</td>\n<td>\n<p>Abdominal pain, dysphagia, vomiting, bloody or rice water diarrhea, mucosal erosions.</p>\n</td>\n<td>\n<p>Nausea, vomiting, diarrhea, anorexia, weight loss</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Liver</p>\n</td>\n<td>\n<p>Fatty infiltration</p>\n</td>\n<td>\n<p>Hepatomegaly, jaundice, cirrhosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Kidney</p>\n</td>\n<td>\n<p>Tubular and glomerular changes – oliguria and uremia</p>\n</td>\n<td>\n<p>Nephritic finding</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Haemetologic</p>\n</td>\n<td>\n<p>thrombocytopenia, impaired folate metabolism</p>\n</td>\n<td>\n<p>Bone marrow hypoplasia, anemia, leukopenia, basophilic stippling, and karyorrhexis.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cardiovascular</p>\n</td>\n<td>\n<ul>\n<li>S-T wave abnormalities,</li>\n<li>Prolonged QT interval</li>\n<li>Ventricular fibrillation</li>\n<li>Atypical ventricular tachycardia</li>\n</ul>\n</td>\n<td>\n<p>There is platelet activation and hypercoagulability of blood in peripheral arteries leading to <strong>Blackfoot disease</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Reproductive system</p>\n</td>\n<td>\n<p>Maternal ingestion of inorganic</p>\n<p>Arsenic crosses the placental barrier and infant death shortly after birth.</p>\n</td>\n<td>\n<p>-Nil-</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "FC0248",
      "difficulty": "medium"
    },
    {
      "text": "A 55-year-old lady presented with chronic pain in the lower back and knees. On physical examination, there were black pigmentary deposits on the sclera of both eyes and on the fingers and nailbeds. The urine turned black on exposure to Benedict's reagent and showed large amounts of a particular metabolite which is responsible. Identify the metabolite from the image below",
      "choices": [
        {
          "id": 1,
          "text": "2"
        },
        {
          "id": 2,
          "text": "1"
        },
        {
          "id": 3,
          "text": "4"
        },
        {
          "id": 4,
          "text": "3"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The clinical vignette is suggestive of <strong>alkaptonuria,&nbsp;</strong>which is characterised by excretion of the metabolite&nbsp;<strong>homogentisate </strong>(marked as <strong>2&nbsp;</strong>in the flowchart)&nbsp;in urine.</p>\n<p>Alkaptonuria is an autosomal recessive disorder of <strong>tyrosine metabolism</strong>. It occurs due to a defect in <strong>homogentisate oxidase</strong>&nbsp;(which&nbsp;oxidizes homogentisate to maleylacetoacetate) leading to the <strong>accumulation of homogentisate</strong>. The&nbsp;excreted homogentisate in urine makes it appear black when it gets oxidized on exposure to air or an oxidizing agent.</p>\n<p>Accumulation of oxidized homogentisic acid pigment (benzoquinone acetate) in joints and connective tissues leads to arthritis and connective tissue pigmentation respectively. This is known as <strong>ochronosis</strong>.&nbsp;Pigmentation of heart valves, larynx, tympanic membranes, and skin, with occasional renal pigment calculi, can also be seen.</p>\n<p>Most patients are diagnosed early based on the<strong> darkening of urine</strong> with standing or the addition of alkali. Around the age of 30 years, gray-brown pigmentation of sclera and generalized darkening of the concha, anthelix and helix of the ear is seen.Some patients present in middle age with a <strong>degenerative joint disease</strong> (ochronotic arthritis) with pain, stiffness, and limitation of motion of the lower back, hips, knees, and shoulders. Small joints are usually spared.</p>\n<p>Treatment:</p>\n<div class=\"page\" title=\"Page 3065\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li><strong>Symptomatic</strong> treatment with pain medications, spinal surgery, and arthroplasty&nbsp;</li>\n<li>Ascorbic acid and protein restriction&nbsp;</li>\n<li><strong>Nitisinone</strong> - reduces urinary excretion of homogentisic acid and delays progression of the disease.</li>\n</ul>\n</div>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0fe5b17563d94403887314b8c37e2099x1280x2566.3187588152327.JPEG\" alt=\"Explanation Image\"><p>The images below show<strong> pigmentation of the skin </strong>and an<strong> x-ray of the spine </strong>that shows<strong> calcification of intervertebral discs,</strong> both symptoms of ochronosis.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/69bb0d10ce66436eb0e4e36807c443aex408x267.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/114c954855d74f0cbc4ab61cf0d8073fx972x1198.JPEG\" alt=\"Explanation Image\"><p>Image showing darkening of urine on standing:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/94e733d3439e40659d77dd54cc40ce9dx512x358.PNG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Amino acid Enzymatic Disorders and the Associated Enzymes</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disorder</strong></p>\n</td>\n<td>\n<p><strong>Enzyme defect</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Phenylketonuria</p>\n</td>\n<td>\n<p>Phenylalanine hydroxylase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tyrosinosis (Tyrosinemia type I)</p>\n</td>\n<td>\n<p>Maleyl Acetate isomerase or Fumarylacetoacetate hydrolase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maple syrup urine disease&nbsp;</p>\n</td>\n<td>\n<p>Branched-chain alpha-keto acid dehydrogenase(BCKAD)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Alkaptonuria</p>\n</td>\n<td>\n<p>Homogentisate oxidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Albinism</p>\n</td>\n<td>\n<p>Tyrosinase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Homocystinuria type I</p>\n</td>\n<td>\n<p>Cystathionine synthase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Homocystinuria type II</p>\n</td>\n<td>\n<p>Defect in methylcobalamin formation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cystathioninuria</p>\n</td>\n<td>\n<p>Cystathionase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tyrosinemia type II or Richner-Hanhart syndrome</p>\n</td>\n<td>\n<p>Tyrosine transaminase or Tyrosine aminotransferase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Primary hyperoxaluria</p>\n</td>\n<td>\n<p>Alanine glyoxalate aminotransferase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypervalinemia</p>\n</td>\n<td>\n<p>Valine transaminase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Isovaleric acidemia</p>\n</td>\n<td>\n<p>Isovaleryl CoA dehydrogenase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Histidinemia</p>\n</td>\n<td>\n<p>Histidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hyperprolinemia type I</p>\n</td>\n<td>\n<p>Proline oxidase</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/cd74d0fa7ff04732a5f61cff999500c8.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "FC0247",
      "difficulty": "medium"
    },
    {
      "text": "An undernourished child is brought for consultation. You prescribe a mineral supplement that is absorbed by the mechanism shown in the image below. Identify the supplement.",
      "choices": [
        {
          "id": 1,
          "text": "Copper"
        },
        {
          "id": 2,
          "text": "Iron"
        },
        {
          "id": 3,
          "text": "Calcium"
        },
        {
          "id": 4,
          "text": "Zinc"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given image shows <strong>iron absorption and transport</strong> from a duodenal enterocyte into the blood, hence the mineral supplement prescribed can be identified as an <strong>iron</strong> supplement.</p>\n<p>The following image shows in detail, the absorption of iron from a duodenal enterocyte.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/434650ea843645ec80e4a24389d0209dx1280x1210.JPEG\" alt=\"Explanation Image\"><p>Dietary iron is available in two forms - heme and non-heme iron. Initially, the ferric <strong>non-heme iron</strong> is <strong>reduced</strong> to ferrous iron by <strong>duodenal cytochrome B (ferric reductase)</strong>&nbsp;or by <strong>vitamin C</strong>.<strong>&nbsp;</strong>The reduced ferrous iron is then transferred into the enterocyte by <strong>DMT 1 (divalent metal transporter)</strong>.&nbsp;</p>\n<p>Heme iron moves into the cytoplasm with the help of transporters. Here, it is metabolized to release ferrous iron, which then follows the same pathway as non-heme iron.</p>\n<p>Once inside the enterocyte, it can <strong>either</strong> get <strong>stored as ferritin</strong> or <strong>transferred</strong> across the basolateral membrane<strong> by ferroportin.</strong>&nbsp;In the <strong>plasma</strong>, iron is transported in the <strong>Fe<sup>3+</sup> form bound to transferrin</strong>, which is a transport protein. Hephaestin is a ferroxidase that oxidizes Fe<sup>2+</sup> to Fe<sup>3+</sup> before it is transported.</p>\n<p><strong>Hepcidin</strong>, a protein secreted from the liver plays a major role in the regulation of iron absorption. When the body&rsquo;s iron stores are adequate it downregulates the expression of <strong>ferroportin</strong> and thereby iron absorption too. Thus,<strong> iron is trapped</strong> in the intestinal cells which is eventually sloughed off. Hepcidin also <strong>inhibits</strong> the release of <strong>iron from macrophages</strong> by binding to ferroportin.&nbsp;High hepcidin levels are seen in systemic inflammation and low hepcidin levels are seen in hemochromatosis.</p>\n<p><strong>Iron</strong> is an important <strong>component</strong> of</p>\n<ul>\n<li>Hemoglobin</li>\n<li>Myoglobin</li>\n<li>Cytochrome P450 groups of enzymes</li>\n<li>Components of the electron transport chain</li>\n<li>Ribonucleotide reductase</li>\n</ul><hr><h3>Related Pearl: Factors affecting iron absorption</h3><p><strong>Enhancers:</strong></p>\n<ul>\n<li>Ascorbic acid</li>\n<li>Citric acid</li>\n<li>Amino acid</li>\n<li>Sugars in the diet</li>\n</ul>\n<p><strong>Inhibitors:</strong></p>\n<ul>\n<li>Tannins</li>\n<li>Carbonate</li>\n<li>Oxalate</li>\n<li>Phosphate</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/d0f7a03d5e45407ba5514ff7eaadc941.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "FC0239",
      "difficulty": "easy"
    },
    {
      "text": "A 22-year-old woman presented with a 2-week history of progressive severe headache and blurry vision. Clinical examination was significant for bilateral papilledema. A lumbar puncture revealed elevated opening pressure with normal CSF composition. An MRI showed no space-occupying lesions. On further questioning, she admits to taking high-dose multivitamin supplements. Which vitamin excess is likely to cause the above scenario?",
      "choices": [
        {
          "id": 1,
          "text": "Vitamin A"
        },
        {
          "id": 2,
          "text": "Vitamin D"
        },
        {
          "id": 3,
          "text": "Vitamin E"
        },
        {
          "id": 4,
          "text": "Vitamin K"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The clinical scenario of increased intracranial pressure in the absence of space-occupying lesion points towards the diagnosis of <strong>pseudotumor cerebri</strong>. <strong>Vitamin A excess</strong> is the likely cause.</p>\n<p><strong>Clinical features</strong> of hypervitaminosis A:</p>\n<ul>\n<li><strong>CNS:</strong>&nbsp;Symptoms of raised intracranial pressure (<strong>pseudotumor cerebri</strong>) such as headache, nausea, vomiting, blurring of vision, ataxia, anorexia</li>\n<li><strong>Liver</strong>: Hepatomegaly and hyperlipidemia</li>\n<li><strong>Musculoskeletal</strong>: Thickening of the long bones (<strong>bony exostosis</strong>), hypercalcemia, soft tissue calcification</li>\n<li><strong>Dermatological</strong>: Dryness, <strong>exfoliative dermatitis</strong>, alopecia</li>\n<li><strong>Teratogenesis</strong>: Pregnant women should not ingest excessive quantities as it can cause congenital malformations in the developing fetus.&nbsp;<strong>Isotretinoin</strong>(13-cis retinoic acid) is a drug that is<strong> teratogenic </strong>and absolutely <strong>contraindicated </strong>in<strong> pregnancy.</strong></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "FC0256",
      "difficulty": "easy"
    },
    {
      "text": "What is the correct sequence of events in Southern blotting?<div class='question-desc-html'><p>1 - Transfer to a membrane<br />2 - Hybridization with a labeled probe sequence<br />3 - Separation of DNA fragments by electrophoresis</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 2, 3"
        },
        {
          "id": 2,
          "text": "2, 1, 3"
        },
        {
          "id": 3,
          "text": "3, 1, 2"
        },
        {
          "id": 4,
          "text": "2, 3, 1"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In Southern blotting<strong> DNA fragments </strong>are first separated by<strong> electrophoresis.</strong></p>\n<ul>\n<li>The DNA in the gel is then made single-stranded by exposure to dilute alkali, and transferred by capillary action to the nylon membrane, which is laid over it. The relative positions of the different DNA fragments are thus preserved on the membrane.</li>\n<li>The membrane is then soaked in buffer containing the labelled probe, which base pairs with the DNA fragment of interest.</li>\n<li>The position of that fragment is then determined by autoradiographic (exposure of the membrane to X-ray film), or fluorescent detection of the hybridized probe.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7a976265f58f462db822daefeb3bf6a9x800x494.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "FC0254",
      "difficulty": "medium"
    },
    {
      "text": "A 26-year-old female patient comes with a history of chronic weight loss, loss of appetite, and diarrhea along with pale bulky stools and is diagnosed with malabsorption syndrome. Steatorrhea is defined in this patient by stool fat exceeding:",
      "choices": [
        {
          "id": 1,
          "text": "7 g per day"
        },
        {
          "id": 2,
          "text": "14 g per day"
        },
        {
          "id": 3,
          "text": "28 g per day"
        },
        {
          "id": 4,
          "text": "32 g per day"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Steatorrhea is a symptom&nbsp;defined by stool fat exceeding <strong>7 g per day.</strong></p>\n<p>Steatorrhea is the passage of <strong>greasy, foul-smelling, difficult-to-flush</strong> stools.&nbsp;It is often associated with weight loss &amp; nutritional deficiencies due to concomitant malabsorption of amino acids &amp; fat-soluble vitamins. It is one of the clinical features of <strong>fat malabsorption</strong> and is noted in many conditions causing intraluminal maldigestion, mucosal malabsorption, or lymphatic obstruction.</p>\n<p>Causes of steatorrhea:</p>\n<ul>\n<li class=\"half_rhythm\">\n<div>Exocrine <strong>pancreatic insufficiency</strong>: Chronic pancreatitis, cystic fibrosis (CF), pancreatic tumors</div>\n</li>\n<li class=\"half_rhythm\">\n<div><strong>Bile acid deficiency</strong>: Primary biliary cholangitis&nbsp;(PBC), primary sclerosing cholangitis (PSC), ileal resection, Crohn disease, small&nbsp;intestinal bacterial overgrowth (SIBO)</div>\n</li>\n<li class=\"half_rhythm\">\n<div><strong>Enteropathy </strong>or<strong>&nbsp;</strong>Malabsorption syndrome: Celiac disease (most common), tropical sprue, giardiasis, Whipple disease, amyloidosis, SIBO, abetalipoproteinemia</div>\n</li>\n</ul>\n<p>Screening of steatorrhea is by the detection of fat&nbsp;by <strong>Sudan III staining. </strong>Stool fat can be quantified&nbsp;by calculating the coefficient of fat absorption <strong>(CFA), </strong>which is an essential step in the diagnosis.</p>\n<p>The following are the general tests for malabsorption:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Disorder</strong></td>\n<td><strong>Investigation</strong></td>\n</tr>\n<tr>\n<td>Fat malabsorption</td>\n<td>\n<p>Quantitative: 24h fecal fat &gt;7g</p>\n<p>Qualitative: Sudan III staining</p>\n<p>C<sup>14</sup>&nbsp;Triolein breath test</p>\n<p>Fecal steatocrit</p>\n</td>\n</tr>\n<tr>\n<td>Carbohydrate malabsorption</td>\n<td>\n<p>D-xylose test</p>\n<p>Lactose hydrogen breath test</p>\n</td>\n</tr>\n<tr>\n<td>Protein malabsorption</td>\n<td>C<sup>13</sup>&nbsp;egg-white breath test</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>The following are the specific tests for malabsorption:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Disorder</strong></td>\n<td><strong>Investigation</strong></td>\n</tr>\n<tr>\n<td>Celiac disease</td>\n<td>\n<p>Anti-tissue transglutaminase (anti-tTG)</p>\n<p>Anti-endomysial antibodies</p>\n<p>Mucosal biopsy showing villous atrophy, crypt hyperplasia, lamina propria infiltrates, and normal mucosal thickness.</p>\n</td>\n</tr>\n<tr>\n<td>Whipple's disease</td>\n<td>Mucosal biopsy showing PAS +ve macrophages in lamina propria</td>\n</tr>\n<tr>\n<td>Pancreatic insufficiency</td>\n<td>\n<p>Fecal elastase</p>\n<p>Fecal chymotrypsin</p>\n</td>\n</tr>\n<tr>\n<td>Small intestinal bacterial overgrowth (SIBO)</td>\n<td>\n<p>Due to Enterobacter or Pseudomonas - jejunal aspirate&nbsp;&gt;10<sup>3</sup>&nbsp;CFU</p>\n<p>Due to other organisms - jejunal aspirate&nbsp;&gt;10<sup>5</sup>&nbsp;CFU</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "FC0237",
      "difficulty": "hard"
    },
    {
      "text": "You are evaluating the metabolic changes in patients with various conditions. Increased basal metabolic rate will be seen in patients with which of the following condition?",
      "choices": [
        {
          "id": 1,
          "text": "Acromegaly"
        },
        {
          "id": 2,
          "text": "Starvation"
        },
        {
          "id": 3,
          "text": "Protein energy malnutrition"
        },
        {
          "id": 4,
          "text": "Addison disease"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Increased basal metabolic rate (BMR)</strong> is seen in patients with <strong>acromegaly</strong>.</p>\n<p><strong>High energy-requiring states</strong> such as fever, pregnancy, pheochromocytoma, adrenergic agonist drugs, cancer, congestive heart failure, <strong>acromegaly</strong>, polycythemia, and Paget&rsquo;s disease of the bone are associated with high BMR. Obesity, <strong>starvation</strong> or anorexia, hypogonadism, <strong>Addison's</strong> syndrome, and immobilization are associated with <strong>low BMR.</strong></p>\n<p><strong>BMR</strong> is the energy required by an awake individual during rest. It is the minimum energy required to carry out vital functions of the body such as respiration, circulation, etc.&nbsp;</p>\n<p>It is calculated using oxygen consumption, calorific value (energy produced by 1 liter of oxygen), and surface area.</p>\n<p><strong>BMR</strong> is dependent on various factors:</p>\n<ul>\n<li><strong>Men</strong> have <strong>more BMR</strong> than women of the same body weight and age because women&rsquo;s bodies contain proportionally more adipose tissue and fewer muscles.&nbsp;</li>\n<li><strong>Elderly people</strong> have <strong>less BMR</strong>&nbsp;as the muscle tissue gets infiltrated with fat as age advances.</li>\n<li>Low environmental temperature is associated with high BMI.</li>\n<li>Exercise increases BMR.</li>\n<li>The thyroid hormone has a direct role in increasing BMR.</li>\n</ul><hr><h3>Related Pearl: Basal Metabolic Rate</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>BMR is increased in</strong></p>\n</td>\n<td>\n<p><strong>BMR is decreased in</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Fever</p>\n</td>\n<td>\n<p>Protein energy malnutrition</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hyperthyroidism</p>\n</td>\n<td>\n<p>Hypothyroidism</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cold environment</p>\n</td>\n<td>\n<p>Addison disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cushing&rsquo;s syndrome</p>\n</td>\n<td rowspan=\"2\">\n<p>Starvation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cachexia</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "FC0245",
      "difficulty": "medium"
    },
    {
      "text": "Match the following urine tests with respective substances they detect.<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Test</strong></p>\n</td>\n<td><strong>Substance</strong></td>\n</tr>\n<tr>\n<td>\n<p>1. Rothera test</p>\n</td>\n<td>A. Urobilinogen</td>\n</tr>\n<tr>\n<td>\n<p>2. Benedict's test</p>\n</td>\n<td>B. Bile salts</td>\n</tr>\n<tr>\n<td>\n<p>3. Hay's test</p>\n</td>\n<td>C. Glucose</td>\n</tr>\n<tr>\n<td>\n<p>4. Ehrlich's test</p>\n</td>\n<td>D. Acetoacetate</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "1-D, 2-A, 3-B, 4-C"
        },
        {
          "id": 2,
          "text": "1-D, 2-C, 3-B, 4-A"
        },
        {
          "id": 3,
          "text": "1-D, 2-C, 3-A, 4-B"
        },
        {
          "id": 4,
          "text": "1-A, 2-C, 3-B, 4-D"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The correctly matched option is&nbsp;<strong>1-D, 2-C, 3-B,</strong><strong>&nbsp;4-A.</strong></p>\n<p><strong>Rothera&rsquo;s test</strong>&nbsp;by&nbsp;<strong>nitroprusside reagent</strong>&nbsp;is a specific test used to detect whether&nbsp;<strong>acetone</strong>&nbsp;or&nbsp;<strong>acetoacetate</strong>&nbsp;is present in the given sample of urine. A&nbsp;<strong>purple ring</strong>&nbsp;at the junction of two liquids indicates a positive test. Rothera's test does&nbsp;<strong>not detect</strong>&nbsp;&beta;-hydroxybutyrate.&nbsp;&nbsp;</p>\n<p>The other test used for the purpose of detecting <strong>acetoacetate</strong> <strong>only</strong> is the <strong>ferric chloride test</strong>. It shows a burgundy red color that is graded from +1 to +4. False-positive results occur with drugs like salicylates and phenols.&nbsp;</p>\n<p>The image below shows the purple ring formed by a positive Rothera test.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/049db47cd2da4b4a8c7d42d7e9ae4d46x720x540.JPEG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p><strong>Benedict's test</strong> is a test commonly used in the follow-up of diabetics for the detection of <strong>glucose</strong> in urine (glucosuria). It uses Benedict's reagent containing sodium carbonate, copper sulfate, and sodium citrate. <strong>Reducing sugars </strong>(containing a free aldehyde/ keto group) will reduce Benedict's reagent. Examples include glucose, fructose, and lactose.</p>\n<div class=\"page\" title=\"Page 333\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The test is a semi-quantitative test. The blue color indicates no reducing sugar.&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Color</strong></td>\n<td><strong>Concentration</strong></td>\n</tr>\n<tr>\n<td>Green</td>\n<td>0.5 g%</td>\n</tr>\n<tr>\n<td>Yellow</td>\n<td>1 g%</td>\n</tr>\n<tr>\n<td>Orange</td>\n<td>1.5 g%</td>\n</tr>\n<tr>\n<td>Red</td>\n<td>2 g%</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/95a57e39e46642aa9585b57c2b99553ax720x404.JPEG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p><strong>Hay's test </strong>is used for the detection of<strong> bile salts </strong>in<strong>&nbsp;urine.&nbsp;</strong>Normally, bile salts (sodium salts of taurocholic acid and glycocholic acid) are not present in urine. Thus, <strong>positive Hay's test</strong> indicates an <strong>obstructive</strong> pathology in the biliary system, leading to the backflow of bile into the circulation. This obstruction may be associated with either obstructive jaundice or hepatic jaundice.</p>\n<p><strong>Ehrlich's test&nbsp;</strong>is used to determine urinary&nbsp;and fecal<strong> urobilinogen.</strong>&nbsp;</p>\n<p>Porphobilinogens form a <strong>red aldehyde compound</strong>&nbsp;with Ehrlich reagent, which is insoluble in chloroform. A red color remaining after chloroform extraction is indicative of porphobilinogens. This test is&nbsp;positive in acute intermittent porphyria and hemolytic jaundice. It is negative in hepatic jaundice (later stages) and obstructive jaundice. The earliest sign of recovery in obstructive jaundice is the re-appearance of urobilinogen in urine.</p>\n<p>Normal color of urine is&nbsp;<strong>pale straw</strong>&nbsp;due to presence of&nbsp;<strong>urochrome.</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Abnormality</strong></td>\n<td><strong>Cause</strong></td>\n</tr>\n<tr>\n<td>Smokey or cloudy</td>\n<td>\n<ul>\n<li>AGN</li>\n<li>Nephrotic syndrome</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Gross blood</td>\n<td>\n<ul>\n<li>Urological causes&nbsp; &nbsp; &nbsp;</li>\n<li>Nephro causes</li>\n<li>Hematological causes, e.g. PNH</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Red without blood [brownish tinge]</td>\n<td>\n<ul>\n<li>Rhabdomyolysis&nbsp; &nbsp;</li>\n<li>Beetroot ingestion&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Tea- or cola-colored urine</td>\n<td>Hemoglobinuria</td>\n</tr>\n<tr>\n<td>High-colored urine</td>\n<td>Bilirubinuria</td>\n</tr>\n<tr>\n<td>Darkens on standing</td>\n<td>Alkaptonuria</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>&nbsp;Due to Drugs:&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Abnormality&nbsp;</strong></td>\n<td><strong>Drugs&nbsp;</strong></td>\n</tr>\n<tr>\n<td>Orange</td>\n<td>\n<ul>\n<li>Rifamycins (rifampicin, rifabutin, rifapentine)</li>\n<li>B-complex&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Blue</td>\n<td>\n<ul>\n<li>Amitriptyline</li>\n<li>Methylene blue</li>\n<li>Copper poisoning</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Brown</td>\n<td>\n<ul>\n<li>Chloroquine</li>\n<li>Quinine</li>\n<li>Primaquine</li>\n<li>Nitrofurantoin&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Yellow</td>\n<td>Tetracycline&nbsp;</td>\n</tr>\n<tr>\n<td>Pinkish</td>\n<td>Deferoxamine</td>\n</tr>\n<tr>\n<td>Green</td>\n<td>Triamterene</td>\n</tr>\n<tr>\n<td>Darkens on standing</td>\n<td>\n<ul>\n<li>Metronidazole</li>\n<li>Methyldopa</li>\n<li>Imipenem-cilastin</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "FC0255",
      "difficulty": "medium"
    },
    {
      "text": "A 60-year-old patient presented to the casualty in an unconscious state. His blood sugars were high, the ABG(Arterial blood gas) analysis showed metabolic acidosis, and urine tests were positive for ketone bodies. The ketone bodies were not utilized in the liver because it lacks the enzyme:",
      "choices": [
        {
          "id": 1,
          "text": "β hydroxybutyrate dehydrogenase"
        },
        {
          "id": 2,
          "text": "Thiophorase"
        },
        {
          "id": 3,
          "text": "Thiolase"
        },
        {
          "id": 4,
          "text": "Ketoacyl reductase"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Ketone bodies are not utilized in the <strong>liver</strong> because it <strong>lacks</strong> the enzyme<strong> thiophorase.</strong></p>\n<p>The above clinical scenario points to the diagnosis of <strong>diabetic ketoacidosis</strong> characterized by excess production of ketone bodies. The liver cannot utilize the ketone bodies (acetoacetate, &beta;-hydroxybutyrate, and acetone) because it lacks the enzyme thiophorase (also called succinyl CoA acetoacetyl CoA transferase).</p>\n<p>Ketone bodies are synthesized in the liver mitochondria (by <strong>ketogenesis</strong>) and transported in the blood to the <strong>peripheral tissues. </strong>Here they are <strong>utilized</strong> by the following steps:</p>\n<ol>\n<li>&beta;-hydroxybutyrate (the most predominant ketone body) is oxidized to acetoacetate by <strong>&beta;-hydroxybutyrate dehydrogenase</strong> producing NADH.</li>\n<li>Acetoacetate is then activated to acetoacetyl CoA by transferring a CoA molecule from succinyl CoA by <strong>succinyl CoA-acetoacetyl CoA transferase (thiophorase).</strong></li>\n<li>Acetoacetyl CoA is cleaved into two acetyl CoA molecules by <strong>thiolase</strong> and oxidized into CO<sub>2</sub> by the TCA cycle.</li>\n</ol>\n<div class=\"page\" title=\"Page 226\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>When higher than normal ketone bodies are present in the blood or urine, it is called <strong>ketonemia</strong> or <strong>ketonuria</strong>, respectively. The overall condition is called <strong>ketosis</strong>. The metabolism of free fatty acids to produce ketone bodies is exaggerated in pathologic states such as <strong>starvation</strong> and <strong>diabetes</strong> <strong>mellitus</strong>, thus causing ketosis. The continued buffering and excretion of ketone bodies deplete the alkali reserve, causing <strong>ketoacidosis</strong>.</p>\n<p>&nbsp;</p>\n</div>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Ketone body utilisation</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c4f64f2c484149b98ae69f977b81491ax600x597.JPEG\" alt=\"Pearl Image\"><p>1.&nbsp;3-Hydroxybutyrate dehydrogenase</p>\n<p>2.&nbsp;CoA Transferase</p>\n<p>3.&nbsp;Thiolase</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "FC0231",
      "difficulty": "hard"
    },
    {
      "text": "A 4-year-old child has a history of biting his lips and fingers. On evaluation, you notice lip lacerations, missing portions of fingers of his hands, and developmental delay. On inquiry, the parents say that two male cousins on the mother's side with similar complaints have been diagnosed with a genetic disorder. Lab reports reveal hyperuricemia. Which enzyme is most likely deficient in this child?",
      "choices": [
        {
          "id": 1,
          "text": "Purine nucleoside phosphorylase"
        },
        {
          "id": 2,
          "text": "Hypoxanthine-guanine phosphoribosyltransferase"
        },
        {
          "id": 3,
          "text": "Adenine phosphoribosyltransferase"
        },
        {
          "id": 4,
          "text": "Adenosine deaminase"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario of <strong>self-mutilating behavior,</strong> <strong>delayed developmental milestones, positive family history and hyperuricemia</strong> is highly suggestive of <strong>Lesch-Nyhan syndrome</strong>. It occurs due to the <strong>complete deficiency</strong> of<strong> </strong>the enzyme<strong> hypoxanthine-guanine phosphoribosyltransferase (HGPRT) </strong>involved in the salvage pathway.</p>\n<p><strong>Purines</strong> produced in the body or introduced through diet can be converted to <strong>nucleoside triphosphates</strong> to be reused by the body. This pathway is called the <strong>salvage pathway</strong> for purines and is shown below</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d295845ea4924b19ab07ca33a23f65bex1280x1203.JPEG\" alt=\"Explanation Image\"><p>Lesch-Nyhan syndrome is an <strong>X-linked recessive</strong> disorder due to a complete deficiency of the HGPRT enzyme. This deficiency results in an <strong>inability to salvage</strong> hypoxanthine or guanine resulting in increased levels of <strong>phospho-ribosyl pyrophosphate (PRPP)</strong> and decreased levels of inosine monophosphate (IMP) and guanosine monophosphate (GMP). An increase in guanine and hypoxanthine eventually gets converted into <strong>uric acid, </strong>There is <strong>increased de novo purine synthesis.</strong></p>\n<p>The clinical features include <strong>compulsive self-mutilation</strong>, intellectual disability, delayed milestones, dystonic movements, and hyperuricemia. The excess uric acid can form kidney stones (<strong>urolithiasis</strong>) or deposits in joints as urate crystals (<strong>gouty arthritis</strong>).</p>\n<p>The treatment of this condition includes:</p>\n<ul>\n<li><strong>Allopurinol</strong> or febuxostat for hyperuricemia</li>\n<li>Behavioural management using restraints for self-mutilation</li>\n<li>High fluid intake, reduced fructose and purine intake</li>\n</ul>\n<p><strong>Partial deficiency</strong> of <strong>HGPRT</strong> leads to <strong>Kelley-Seegmiller syndrome.</strong></p>\n<p>Other options:</p>\n<p>Option A: <strong>Purine nucleoside phosphorylase</strong> deficiency leads to severe T-cell deficiency with normal B-cell function. Patients present with autoimmune diseases and opportunistic infections.</p>\n<p>Option C: <strong>Adenine phosphoribosyltransferase (APRT) </strong>is another enzyme along with HGPRT to be involved in the salvage of purine bases to nucleotides. </p>\n<p>Option D: <strong>Adenosine deaminase</strong> deficiency leads to sparse or defective T cells and B cells. Patients suffer from severe immunodeficiency and often succumb to fatal infections. </p>\n<div class=\"page\" title=\"Page 346\"> </div><hr><h3>Related Pearl: Purine salvage deficiencies: Lesch-Nyhan syndrome and Adenosine deaminase deficiency(SCID)</h3><p><strong>Severe Combined Immunodeficiency(SCID):</strong></p>\n<p><strong>Adenosine deaminase</strong>&nbsp;enzyme deficiency is one of the major cause of SCID. It is also called as&nbsp;<strong>Glanzmann&ndash;Riniker syndrome.</strong></p>\n<p>SCID patients are usually affected by severe bacterial, viral, or fungal infections early in life and often present with interstitial lung disease, chronic diarrhea, and failure to thrive.</p>\n<p><strong>Lesch-Nyhan syndrome:</strong></p>\n<p>It is due to deficiency of the enzyme<strong> Hypoxanthine-guanine phosphoribosyltransferase(HGPRT). </strong>It is an X-linked recessive disease.</p>\n<p>Clinical features:</p>\n<ul>\n<li><span class=\"fontstyle0\">Intellectual disability</span></li>\n<li><span class=\"fontstyle0\">Self-mutilation</span></li>\n<li><span class=\"fontstyle0\">Aggression</span></li>\n<li>Hyperuricemia&nbsp;</li>\n<li><span class=\"fontstyle0\">Gout<br /></span></li>\n</ul>\n<p><span class=\"fontstyle0\">Treatment:</span></p>\n<ul>\n<li><span class=\"fontstyle0\">Allopurinol</span></li>\n<li><span class=\"fontstyle0\">Febuxostat</span></li>\n</ul><hr><h3>Related Pearl: Enzymes and Steps Involved in Purine Degradation</h3><table>\n<tbody>\n<tr>\n<td>\n<p>Enzymes</p>\n</td>\n<td>\n<p>Reaction</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>AMP deaminase</p>\n</td>\n<td>\n<p>AMP to IMP</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Adenosine deaminase</p>\n</td>\n<td>\n<p>Adenosine to Inosine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>5'-nucleotidase</p>\n</td>\n<td>\n<p>IMP &amp; GMP to Inosine &amp; Guanosine respectively</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Purine nucleoside phosphorylase</p>\n</td>\n<td>\n<p>Inosine &amp; Guanosine to Hypoxanthine &amp; guanine respectively</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Xanthine oxidase</p>\n</td>\n<td>\n<p>Hypoxanthine to Xanthine &amp; Xanthine to uric acid</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "FC0249",
      "difficulty": "easy"
    },
    {
      "text": "An exclusively breastfed newborn was brought with vomiting and diarrhea that developed since birth. On examination, the baby is jaundiced and has hepatomegaly. Blood glucose level was low and erythrocyte galactose-1-phosphate level was elevated. What is the diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Fructosuria"
        },
        {
          "id": 2,
          "text": "von Gierke's disease"
        },
        {
          "id": 3,
          "text": "Classical galactosemia"
        },
        {
          "id": 4,
          "text": "Hereditary fructose intolerance"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The clinical scenario of an exclusively breastfed infant with vomiting, diarrhea, jaundice, hypotonia, and hepatomegaly with elevated erythrocyte galactose-1-phosphate level is suggestive of <strong>classical galactosemia.</strong></p>\n<p><strong>Classical galactosemia&nbsp;</strong>is an&nbsp;autosomal recessive disorder.<strong>&nbsp;</strong>The enzyme deficient here is&nbsp;<strong>galactose-1-phosphate uridyl transferase </strong>(GALT).<strong>&nbsp;</strong>Normally, newborns receive up to 40% of their calorie intake as lactose (glucose + galactose). Without GALT, the infant cannot metabolize <strong>galactose 1-phosphate,&nbsp;</strong>which&nbsp;accumulates and causes injury to the kidney, liver, and brain.</p>\n<p>Clinical features include <strong>vomiting, hypoglycemia,</strong> hepatomegaly, jaundice, congenital cataracts, aminoaciduria, and&nbsp;<strong>failure to thrive</strong>. There is an increased incidence of&nbsp;<em>Escherichia coli</em> neonatal <strong>sepsis</strong>. Long-term <strong>complications</strong> include speech delays, learning impairment, motor dysfunction, and hypogonadotropic hypogonadism (in females).</p>\n<div class=\"page\" title=\"Page 136\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The presence of galactose in urine (positive Benedict's test), elevated blood galactose level, and elevated&nbsp;erythrocyte galactose-1-phosphate level help in confirming the diagnosis.</p>\n</div>\n</div>\n</div>\n<p>Treatment is a <strong>galactose-free diet</strong>. Supportive therapy and the prevention of complications are important.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/273ae933e27941edbdbe9e4f99d5dbe6x1280x1129.JPEG\" alt=\"Explanation Image\"><p>Other options:</p>\n<p>Option A: <strong>Fructosuria</strong> is due to the deficiency of <strong>fructokinase</strong>. There are no symptoms except for the benign excretion of fructose in urine.</p>\n<p>Option B: <strong>von Gierke's disease</strong> is due to&nbsp;<span data-preserver-spaces=\"true\"><strong>glucose-6-phosphatase</strong>&nbsp;or <strong>translocase</strong> deficiency. It&nbsp;is a&nbsp;<strong>glycogen storage disorder (Type I).&nbsp; </strong>They may<strong>&nbsp;</strong></span><span data-preserver-spaces=\"true\">develop hypoglycemia and lactic acidosis in the neonatal period, but hepatomegaly usually develops at 3&ndash;4 months. They may</span>&nbsp;have doll-like facies, short stature, and a protuberant abdomen. Hyperuricemia, the elevation of triglycerides, low-density lipoproteins, and phospholipids are seen.</p>\n<p>Option D:<strong> Hereditary fructose intolerance</strong> is due to a deficiency of<strong> fructose 1, 6-bisphosphate aldolase (aldolase B)</strong>. Patients are healthy and symptom-free until fructose or sucrose is ingested. Clinical manifestations may include jaundice, hepatomegaly, vomiting, lethargy, irritability, and convulsions. It will not be seen in newborns who are exclusively on breast milk.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "FC0230",
      "difficulty": "medium"
    },
    {
      "text": "A 15-month-old child is brought because of developmental delay and clouded appearance of the cornea in both eyes. The other examination findings of the child are shown in the image below. The elder sibling of the child also has similar findings. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Mucopolysaccharidoses"
        },
        {
          "id": 2,
          "text": "Von Gierke’s disease"
        },
        {
          "id": 3,
          "text": "Down’s syndrome"
        },
        {
          "id": 4,
          "text": "Refsum disease"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given image shows coarse facial features, umbilical hernia, claw hand, and thoracolumbar gibbus. These features along with corneal opacity and developmental delay are highly suggestive of <strong>mucopolysaccharidoses (MPS)</strong>.</p>\n<p>The features mentioned in the above question are suggestive of <strong>MPS type 1</strong>. It is caused by the deficiency of <strong>&alpha;-l-iduronidase</strong>, leading to the storage of dermatan and heparan sulfate. The classical form of MPS 1 is known as <strong>Hurler syndrome</strong>, the intermediate form as <strong>Hurler&ndash;Scheie</strong>, and the most attenuated form is known as <strong>Scheie syndrome</strong>.</p>\n<p>Mucopolysaccharidoses <strong>(MPS)</strong> are a group of genetic disorders (inborn errors of metabolism) affecting <strong>glycosaminoglycans</strong> (GAGs). They are inherited in an<strong> autosomal recessive </strong>manner and involve mutations of genes encoding <strong>lysosomal hydroxylases</strong>.&nbsp;Diagnosis is by demonstration of GAGs in urine or tissue biopsy samples, assays of suspected defective enzymes in white blood cells, fibroblasts, or serum, and testing for specific genes.</p>\n<p>The given image shows cloudy cornea in mucopolysaccharidosis:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d08c76ac37d3434aaadbe26cc4fb9755x300x254.PNG\" alt=\"Explanation Image\"><p>Other options -</p>\n<p>Option B: <strong>Von Gierke&rsquo;s disease </strong>or glycogen storage disease type 1a - Occurs due to the deficiency of glucose-6-phosphatase, and affected children present with hepatosplenomegaly and fasting hypoglycemia.</p>\n<p>Option C: <strong>Down's syndrome</strong>&nbsp;occurs due to trisomy 21. Affected children present with a flattened facial profile,&nbsp;oblique palpebral fissures, and epicanthic folds. Patients may be intellectually disabled.</p>\n<p>Option D: <strong>Refsum disease&nbsp;</strong>- It is a disorder of fatty acid metabolism. It occurs due to deficiency of <strong>alpha-hydroxylase</strong> causing <strong>phytanic acid accumulation</strong> in the tissues. It presents with neurological symptoms, cerebellar ataxia, retinitis pigmentosa, and polyneuropathy.</p><table>\n<tbody>\n<tr>\n<td><strong>Disease</strong></td>\n<td><strong>MPS</strong></td>\n<td><strong>Enzyme defective</strong></td>\n<td><strong>GAGs affected</strong></td>\n<td><strong>Symptoms</strong></td>\n</tr>\n<tr>\n<td>Hurler-, Scheie-,&nbsp;<br />Hurler-scheie syndrome</td>\n<td>MPS I</td>\n<td>&alpha;-L-Iduronidase</td>\n<td>\n<p>Dermatan sulfate,<br />Heparan sulfate</p>\n</td>\n<td>Mental retardation,<br />coarse facial features,&nbsp;<br />Hepatosplenomegaly<br />Cloudy cornea</td>\n</tr>\n<tr>\n<td>Hunter syndrome</td>\n<td>MPS II</td>\n<td>Iduronate sulfatase</td>\n<td>Dermatan sulfate,&nbsp;<br />Heparan sulfate</td>\n<td>Mental retardation</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome A</td>\n<td>MPS IIIA</td>\n<td>Heparan sulfate-N-sulfatase</td>\n<td>Heparan sulfate</td>\n<td>Delay in development<br />Motor dysfunction</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome B</td>\n<td>MPS III B</td>\n<td>&alpha;-N-Acetylglucosaminidase</td>\n<td>Heparan sulfate</td>\n<td>As MPS III A</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome C</td>\n<td>MPS III C</td>\n<td>&alpha;-glucosaminide N-acetyltransferase</td>\n<td>Heparan sulfate</td>\n<td>As MPS III A &nbsp;</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome D</td>\n<td>MPS III D</td>\n<td>N-acetylglucosamine 6-sulfatase</td>\n<td>Heparan sulfate</td>\n<td>As MPS III A &nbsp;</td>\n</tr>\n<tr>\n<td>Morquio syndrome A</td>\n<td>MPS IV A</td>\n<td>Galactosamine&nbsp;6-sulfatase</td>\n<td>Keratan sulfate&nbsp;<br />Chondroitin 6-sulfate&nbsp;</td>\n<td>Skeletal dysplasia<br />short stature</td>\n</tr>\n<tr>\n<td>Morquio syndrome B</td>\n<td>MPS IV B</td>\n<td>&beta;-galactosidase</td>\n<td>Keratan sulfate</td>\n<td>As MPS IV A</td>\n</tr>\n<tr>\n<td>Maroteaux-lamy&nbsp;syndrome&nbsp;</td>\n<td>MPS VI</td>\n<td>N-acetylgalactosamine 4-sulfatase</td>\n<td>Dermatan sulfate</td>\n<td>Curative of spine,<br />Short stature<br />Skeletal dysplasia<br />Cardiac defects</td>\n</tr>\n<tr>\n<td>Sly&nbsp;syndrome&nbsp;</td>\n<td>MPS VII</td>\n<td>&beta;-glucuronidase</td>\n<td>Dermatan sulfate<br />Heparan sulfate<br />Chondroitin 4-sulfate&nbsp;<br />Chondroitin 6-sulfate&nbsp;<br /><br /></td>\n<td>Short stature<br />Skeletal dysplasia<br />Hepatomegaly<br />Cloudy cornea</td>\n</tr>\n<tr>\n<td>Natowicz&nbsp;syndrome&nbsp;</td>\n<td>MPS IX</td>\n<td>Hyaluronidase</td>\n<td>Hyaluronic acid</td>\n<td>Joint Pain<br />Short stature&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/8daac3edfe034dd4a3b878b6640c5e67.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "FC0246",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following phospholipids is found only in the mitochondria and helps in the mitochondrial function ?",
      "choices": [
        {
          "id": 1,
          "text": "Cephalin"
        },
        {
          "id": 2,
          "text": "Cardiolipin"
        },
        {
          "id": 3,
          "text": "Lecithin"
        },
        {
          "id": 4,
          "text": "Plasmalogen"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Cardiolipin</strong> is the phospholipid found <strong>only</strong> in the <strong>mitochondria. </strong></p>\n<p>It is an important component of the <strong>inner mitochondrial membrane</strong>, where it is essential for the following:</p>\n<ul>\n<li><strong>Optimal function</strong> of numerous mitochondrial enzymes that are involved in mitochondrial <strong>energy metabolism</strong>.</li>\n<li><strong>Maintenance of the structure</strong> of the mitochondrial membrane.</li>\n</ul>\n<p>Clinical correlate:</p>\n<p><strong>Decreased cardiolipin</strong> or alteration in its metabolism results in<strong> </strong>mitochondrial dysfunction<strong> </strong>seen in<strong> Barth syndrome (cardioskeletal myopathy)</strong> which is <span class=\"ILfuVd\"><span class=\"hgKElc\">characterized by an enlarged and weakened heart (<strong>dilated cardiomyopathy</strong> ), weakness in muscles used for movement (<strong>skeletal myopathy</strong>), recurrent infections due to small numbers of white blood cells (<strong>neutropenia</strong>), and <strong>short stature</strong>.</span></span></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "FC0228",
      "difficulty": "medium"
    },
    {
      "text": "A 32-year-old man is found to have right-sided colon cancer. His father had similar colon cancer and died at the age of 40. His paternal aunt suffers from endometrial cancer and his paternal uncle also suffers from urothelial cancer. There is no history of familial adenomatous polyposis. Abnormality in which of the following DNA repair mechanisms is responsible for this patient's condition?",
      "choices": [
        {
          "id": 1,
          "text": "Nucleotide excision repair"
        },
        {
          "id": 2,
          "text": "Homologous recombination"
        },
        {
          "id": 3,
          "text": "Base excision repair"
        },
        {
          "id": 4,
          "text": "Mismatch repair"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given clinical scenario is suggestive of <strong>Lynch syndrome </strong>or<strong> hereditary nonpolyposis colorectal cancer</strong> (HNPCC) and <strong>mismatch repair </strong>is the defective DNA repair mechanism here. </p>\n<p><strong>HNPCC</strong> is an <strong>autosomal dominant</strong> genetic condition that is associated with a high risk of <strong>colon cancer</strong><sup id=\"cite_ref-1\" class=\"reference\"></sup> as well as other cancers including endometrial cancer (second most common), cancers of the stomach, ovary, ureters, etc. It is the most common cause of the syndromic form of colon cancer. Colon cancers are seen at <strong>younger</strong> ages and usually on the <strong>right</strong> side.</p>\n<p>DNA mismatch repair proteins<strong> function as spell checkers</strong> during DNA replication by correcting the <strong>incorrect pairing.</strong> In HNPCC, the proofreading function of the mismatch repair systems (majorly <strong><em>MLH1 </em></strong><em>and</em><strong> <em>MSH2</em></strong><em>)</em> is lost leading to the accumulation of errors throughout the genome. The genomes of these patients show <strong>microsatellite instability</strong>, which is characterized by changes in the length of short repeats.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Damaging agents</strong></td>\n<td><strong>Damage caused</strong></td>\n<td><strong>Repair mechanisms</strong></td>\n</tr>\n<tr>\n<td>\n<p>Ionizing radiation</p>\n<p>X-rays</p>\n<p>Anti-tumor drugs</p>\n</td>\n<td>\n<p>Double-strand breaks</p>\n<p>Single-strand breaks</p>\n<p>Intrastrand crosslinks</p>\n<p>Interstrand crosslinks</p>\n</td>\n<td>Non-homologous end joining (NHEJ)</td>\n</tr>\n<tr>\n<td>\n<p>UV light</p>\n<p>Chemicals</p>\n</td>\n<td>\n<p>Bulky adducts</p>\n<p>Pyrimidine dimers</p>\n</td>\n<td>Nucleotide excision repair (NER)</td>\n</tr>\n<tr>\n<td>\n<p>Oxygen radicals</p>\n<p>Hydrolysis </p>\n<p>Alkylating agents</p>\n</td>\n<td>\n<p>Abasic sites single-strand breaks</p>\n<p>8-oxoguanine lesions</p>\n</td>\n<td>Base excision repair (BER)</td>\n</tr>\n<tr>\n<td>Replication errors</td>\n<td>\n<p>Bases mismatch</p>\n<p>Insertions</p>\n<p>Deletions</p>\n</td>\n<td>Mismatch repair (MMR)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Other options:</p>\n<p>Option A: Defects in the <strong>nucleotide excision repair</strong> pathway are seen in patients with <strong>xeroderma pigmentosum.</strong></p>\n<p>Option B: Defects in <strong>non-homologous end-joining</strong> are seen in patients with subacute combined immunodeficiency syndrome <strong>(SCID).</strong></p>\n<p>Option C: Defects in <strong>DNA base excision repair</strong> are seen in patients with MUTYH-associated polyposis (MAP) syndromes. </p><hr><h3>Related Pearl: Amsterdam Criteria II - Revised Criteria for HNPCC</h3><p>The <strong>diagnostic criteria for HNPCC</strong> are referred to as the <strong>Amsterdam criteria</strong><em>&nbsp;</em>or the <strong>3-2-1-0 rule</strong><em>.</em></p>\n<p>It includes the following:</p>\n<ul>\n<li><strong>Three or more relatives</strong> with HNPCC-associated cancer (colorectal cancer, endometrial cancer, cancer of the small bowel, ureter, or renal pelvis), <strong>one of whom is a first-degree relative of the other two</strong></li>\n<li>At least <strong>two successive generations</strong> affected</li>\n<li>At least <strong>one case diagnosed before age 50 years</strong></li>\n<li>Familial adenomatous polyposis excluded</li>\n<li>Tumors verified by pathologic examination.</li>\n</ul>\n<p>&nbsp;</p>\n<p class=\"p1\">&nbsp;</p><hr><h3>Related Pearl: Human Diseases of DNA Damage Repair</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>DNA damage repair type</strong></p>\n</td>\n<td>\n<p><strong>Diseases</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Defective Nonhomologous End Joining Repair (NHEJ)</p>\n</td>\n<td>\n<p>Severe combined immunodeficiency disease (SCID)</p>\n<p>Radiation sensitive severe combined immunodeficiency disease(RS-SCID)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Defective Homologous Repair (HR)</p>\n</td>\n<td>\n<p>AT-like disorder (ATLD)</p>\n<p>Nijmegen breakage syndrome (NBS)</p>\n<p>Bloom syndrome (BS)</p>\n<p>Werner syndrome (WS)</p>\n<p>Rothmund-Thomson syndrome (RTS)</p>\n<p>Breast cancer suspectibility 1 and 2 (BRCA1, BRCA2)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Defective DNA Nucleotide Excision Repair (NER)</p>\n</td>\n<td>\n<p>Xeroderma pigmentosum (XP)</p>\n<p>Cockayne syndrome (CS)</p>\n<p>Trichothiodystrophy (TTD)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Defective DNA Base Excision Repair (BER)</p>\n</td>\n<td>\n<p>MUTYH-associated polyposis (MAP)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Defective DNA Mismatch Repair (MMR)</p>\n</td>\n<td>\n<p>Hereditary nonpolyposis colorectal cancer (HNPCC)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "FC0232",
      "difficulty": "medium"
    },
    {
      "text": "A 9-year-old boy was brought with complaints of a fishy smell in his hands, feet, saliva, and urine. A urinalysis revealed the substance responsible for the odor, and a diagnosis of Fish odor syndrome was made. Which is the substance responsible for this characteristic body odor?",
      "choices": [
        {
          "id": 1,
          "text": "Trimethylamine-N-oxide"
        },
        {
          "id": 2,
          "text": "Trimethylamine"
        },
        {
          "id": 3,
          "text": "Flavin monooxygenase"
        },
        {
          "id": 4,
          "text": "Choline"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>In the given clinical scenario of <strong>fish odor syndrome</strong>, the characteristic odor is due to&nbsp;<strong>trimethylamine (TMA)</strong>, which is released in sweat, urine, and breath.</p>\n<p><strong>Fish odour syndrome</strong>&nbsp;<strong>(trimethylaminuria)</strong> is an autosomal recessive disease. It is due to a deficiency of&nbsp;<strong>flavin-containing monooxygenase 3 (FMO3)</strong> which converts the amino acid, TMA (trimethylamine) to TMA-N-oxide (which is&nbsp;non-odorous) in the liver. <strong>TMA</strong> thus builds up in the body and is released in sweat, urine, and breath, giving off a strong <strong>odor</strong> of <strong>rotting</strong> <strong>fish</strong> from the body.</p>\n<p>Patients present in <strong>childhood</strong> or early adulthood with <strong>halitosis</strong> or <strong>body odor </strong>(distinctive fishy odor). Patients suffer from <strong>psychosocial problems</strong> such as shame, anxiety, depression, etc. Diagnosis is based on high levels of excreted trimethylamine (TMA) in the patient's urine.&nbsp;</p>\n<p>Treatment involves <strong>avoiding foods</strong> containing choline such as egg, liver, peas, and soy products. A <strong>short course of antibiotics</strong> such as neomycin, and metronidazole can be given which reduce the production of trimethylamine by the gut bacteria.</p><hr><h3>Related Pearl: Inborn Errors of Amino Acid Metabolism and Their Associated Urine Odor</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Inborn Error of Metabolism</strong></p>\n</td>\n<td>\n<p><strong>Urine Odor</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maple syrup urine disease</p>\n</td>\n<td>\n<p>Maple syrup</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hawkinsinuria</p>\n</td>\n<td>\n<p>Swimming pool</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>3-Hydroxy-3-methylglutaric aciduria</p>\n</td>\n<td>\n<p>Cat urine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Isovaleric acidemia</p>\n<p>Glutaric acidemia (type II)</p>\n</td>\n<td>\n<p>Sweaty feet</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypermethioninemia</p>\n<p>Tyrosinemia</p>\n</td>\n<td>\n<p>Boiled cabbage</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Multiple carboxylase deficiency</p>\n</td>\n<td>\n<p>Tomcat urine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Phenylketonuria</p>\n</td>\n<td>\n<p>Mousy</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Trimethylaminuria</p>\n</td>\n<td>\n<p>Rotting fish</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Oasthouse syndrome</p>\n</td>\n<td>\n<p>Dried malt/hops</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "FC0234",
      "difficulty": "medium"
    },
    {
      "text": "A patient died due to poisoning with a substance that inhibits the complex of the electron transport chain that is marked in the image below. Which of the following is likely to be the substance?",
      "choices": [
        {
          "id": 1,
          "text": "Rotenone"
        },
        {
          "id": 2,
          "text": "Oligomycin"
        },
        {
          "id": 3,
          "text": "Carbon monoxide"
        },
        {
          "id": 4,
          "text": "Antimycin A"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In the given image, the complex of the electron transport chain shown is<strong> complex IV</strong> and<strong> carbon monoxide</strong> <strong>inhibits complex IV</strong>.</p>\n<div class=\"page\" title=\"Page 74\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Molecules like glucose undergo a series of oxidation reactions to produce CO<sub>2</sub> and water. The metabolic intermediates of these reactions donate electrons to NAD and FAD to form NADH and FADH2. They, in turn, donate a pair of electrons to a specialized set of electron carriers called the electron transport chain. </p>\n<p>The electron chain is present in the inner mitochondrial membrane. It has are 4 protein complexes, named complex-I, II, III, and IV. These complexes are connected by two carriers- co-enzyme Q and cytochrome C. The complexes and their inhibitors are summarized below.</p>\n</div>\n</div>\n</div>\n<table>\n<tbody>\n<tr>\n<td><strong>Complexes of ETC</strong></td>\n<td>  <strong>Inhibitors</strong></td>\n</tr>\n<tr>\n<td><strong>Complex I</strong>: NADH-Q oxidoreductase</td>\n<td>Piericidin, amobarbital, <strong>rotenone</strong></td>\n</tr>\n<tr>\n<td>Complex II: Succinate-Q reductase</td>\n<td>Carboxin, malonate</td>\n</tr>\n<tr>\n<td><strong>Complex III</strong>: Q- cyt c oxidoreductase</td>\n<td>BAL(British anti-lewisite), <strong>antimycin A</strong></td>\n</tr>\n<tr>\n<td><strong>Complex IV</strong>:  cytochrome c oxidase</td>\n<td>Hydrogen sulfide, <strong>carbon monoxide,</strong> <strong>cyanide</strong></td>\n</tr>\n<tr>\n<td> ATP synthase</td>\n<td>Oligomycin</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>\n<p>The following image shows different compounds inhibiting the different components in an electron transport chain.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1e6d472e821e46bd8c023a35fa29cba8x1279x969.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/f9d75a861ecc4acdaf34d5c944fe4f30.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "FC0253",
      "difficulty": "easy"
    },
    {
      "text": "You are studying the visual pigment cycle in the physiology lab. Identify the substance that converts cis-retinal to trans-retinal.",
      "choices": [
        {
          "id": 1,
          "text": "Rhodopsin"
        },
        {
          "id": 2,
          "text": "Scotopsin"
        },
        {
          "id": 3,
          "text": "Metarhodopsin II"
        },
        {
          "id": 4,
          "text": "Lumirhodopsin"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The substance that converts&nbsp;<strong>cis-retinal to trans-retinal</strong> is<strong> rhodopsin. </strong></p>\n<p>Rhodopsin&nbsp;is the visual pigment in the outer segment of&nbsp;rods responsible for scotopic vision (night/ dark vision). It is a light-sensitive pigment and consists of opsin and 11-cis retinal.</p>\n<div class=\"page\" title=\"Page 607\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>When <strong>light</strong> is absorbed by <strong>rhodopsin</strong>, it decomposes very quickly. This leads to an instantaneous change of the <strong>cis form of retinal</strong> <strong>into an all-trans form.&nbsp;</strong>This all-trans-retinal separates from scotopsin to produce bathorhodopsin. Bathorhodopsin is very unstable and decays to form lumirhodopsin, which then decays and forms metarhodopsin I, metarhodopsin II, and finally, into the completely split products scotopsin and all-trans-retinal.&nbsp;</p>\n<div class=\"page\" title=\"Page 608\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 608\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Metarhodopsin II</strong> is also called <strong>activated rhodopsin, </strong>and&nbsp;it produces excitatory changes in the rods, which transmits optic nerve action potentials. to the central nervous system.</p>\n<div class=\"page\" title=\"Page 608\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Re-formation of rhodopsin involves the conversion of the all-trans-retinal back into 11-cis retinal. This requires metabolic energy and is catalyzed by retinal isomerase. 11-cis retinal then recombines with scotopsin to form rhodopsin. Rhodopsin now remains stable until it is triggered by light energy to start decomposing again.</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2e43ca34c9164192b171fa70fed6dc9dx1280x1623.JPEG\" alt=\"Explanation Image\"><div class=\"page\" title=\"Page 608\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Role of vitamin A: The second route of re-formation of rhodopsin involves the conversion of the <strong>all-trans-retinal</strong>&nbsp;into <strong>all-trans-retinol, </strong>which is a&nbsp;form of <strong>vitamin A</strong>. All-trans-retinol is converted into 11- cis retinol by isomerase. 11-cis retinol is then converted into 11-cis retinal, combines with scotopsin, and forms new rhodopsin.</p>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "FC0229",
      "difficulty": "easy"
    },
    {
      "text": "A 5-year-old female child with polyneuropathy, sensorineural deafness, and cerebellar ataxia has the following finding on fundus examination. Lab reveals increased blood levels of phytanic acid. Which of the following is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Refsum's disease"
        },
        {
          "id": 2,
          "text": "Usher syndrome"
        },
        {
          "id": 3,
          "text": "Zellweger syndrome"
        },
        {
          "id": 4,
          "text": "Adrenoleukodystrophy"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The image shows fundoscopy findings of <strong>retinitis pigmentosa</strong>. This along with the given clinical scenario is suggestive of <strong>Refsum&rsquo;s disease.&nbsp;</strong></p>\n<p>Refsum's disease is a rare autosomal recessive disorder that results from the <strong>defect</strong> in <strong>alpha oxidation</strong> of fatty acids such as phytanic acid in the <strong>peroxisome</strong> leading to <strong>elevated levels</strong> of<strong> phytanic acid</strong> in the blood.&nbsp;</p>\n<p>In this condition, the enzyme <strong>phytanoyl CoA hydroxylase</strong> is defective and causes the accumulation of phytanic acid. Clinically, patients present with dysmorphic facies and&nbsp;<strong>severe neurological symptoms </strong>such as&nbsp;polyneuropathy, retinitis pigmentosa, nerve deafness, ichthyosis, and cerebellar ataxia. Regression of symptoms is observed with <strong>restricted dietary intake</strong> of phytanic acid. Therefore, management includes avoiding sources of phytanic acid such as dairy products, meat, nuts, and green leafy vegetables.</p>\n<p>Note: The <strong>Zellwager spectrum</strong> is a continuum of diseases of persoxisome defects with Zellweger syndrome (most severe) at one end, neonatal adrenoleukodystrophy in the middle (intermediate severity) and infantile Refsum's disease (least severe) at the other end.</p>\n<p>Option B-&nbsp;<strong>Usher syndrome</strong>&nbsp;is characterized by <strong>sensorineural deafness </strong>and<strong> retinitis pigmentosa</strong> (but symptoms are not affected by restricting phytanic acid)</p>\n<p>Option C-&nbsp;<strong>Zellweger Syndrome</strong> is also known as <strong>cerebrohepatorenal syndrome.</strong> It is caused by mutations in the&nbsp;PEX/Peroxin<strong>&nbsp;</strong>family of genes involved in peroxisome biogenesis /peroxisomal enzymes.&nbsp;There is severe neurologic symptoms and patients usually die in the 1st year of life.</p>\n<p>Option D-&nbsp;<strong>Adrenoleukodystrophy</strong>&nbsp;is a&nbsp;<strong>disorder</strong> of <strong>&beta;-oxidation</strong> of fatty acids. There is a very large chain fatty acids buildup in the <strong>adrenal glands</strong>, the <strong>white matter</strong> of the brain, and <strong>testes</strong>.</p><hr><h3>Related Pearl: Types, Location and Properties of Fatty acid oxidation</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Types of Oxidation</strong></p>\n</td>\n<td>\n<p><strong>Location</strong></p>\n</td>\n<td>\n<p><strong>Properties</strong></p>\n</td>\n<td>\n<p><strong>Associated Disease</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Beta oxidation</p>\n</td>\n<td>\n<p>Mitochondria</p>\n</td>\n<td>\n<p>A catabolic process by which two-carbons are cleaved from the fatty acid molecule and released as acetyl CoA starting from the carboxyl end.</p>\n<p>The chain is broken between the &alpha;(2) and&nbsp;&beta;(3) carbon.</p>\n<p>1 round of beta-oxidation yield 1FADH2, 1NADH, and 1 Acetyl CoA.</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Alpha oxidation</p>\n</td>\n<td>\n<p>Peroxisome</p>\n</td>\n<td>\n<p>The presence of the 3-methyl group of phytanic acid prevents degradation by beta-oxidation.</p>\n<p>The chain is broken between the terminal carboxyl group and &alpha;(2) carbon removing one carbon at a time.</p>\n<p>It is not an energy-yielding process.</p>\n</td>\n<td>\n<p>Classic Refsum's Disease</p>\n<p>Defective enzyme- Phytanoyl Coa hydroxylase.</p>\n<p>Clinical features include:</p>\n<p>Ichthyosis, Retinitis pigmentosa, Decreased vision, Peripheral neuropathy, Ataxia</p>\n<p class=\"p2\">&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Omega oxidation</p>\n</td>\n<td>\n<p>Endoplasmic Reticulum</p>\n</td>\n<td>\n<p>An alternative pathway to beta-oxidation occurs in microsomes.</p>\n<p>Involves the&nbsp;oxidation&nbsp;of the &omega; carbon (terminal methyl group) resulting in dicarboxylic acid.</p>\n<p>It is not an energy-yielding process.</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Peroxisomal Beta oxidation</p>\n</td>\n<td>\n<p>Peroxisome</p>\n</td>\n<td>\n<p>Very-long-chain fatty acids undergo preliminary &beta;-oxidation in peroxisomes up to&nbsp;octanoyl CoA.&nbsp;The shortened fatty acids undergo further &beta;-oxidation in the mitochondria.</p>\n<p>It is not an energy-yielding process.</p>\n</td>\n<td>\n<p>Zellweger (cerebrohepatorenal) syndrome</p>\n<p>A rare inherited absence of peroxisomes in all tissues.</p>\n<p class=\"p2\">They accumulate C<span class=\"s1\">26</span>&mdash;C<span class=\"s1\">38 </span>polyenoic acids in brain tissue and also exhibit a generalized loss of peroxisomal functions. The disease causes severe neurologic symptoms, and most patients die in the first year of life.</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/f3fafd1946e742bf8e8de730b78c51ba.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "FC0238",
      "difficulty": "medium"
    },
    {
      "text": "While conducting a health camp, you host an awareness campaign on healthy dietary practices. Which of the following substances would you say has the highest respiratory quotient immediately after consumption?",
      "choices": [
        {
          "id": 1,
          "text": "Mixed diet"
        },
        {
          "id": 2,
          "text": "Ghee"
        },
        {
          "id": 3,
          "text": "Wine"
        },
        {
          "id": 4,
          "text": "Meat"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The food item with the <strong>highest respiratory quotient (RQ)</strong> immediately after consumption&nbsp;is a&nbsp;<strong>mixed diet.&nbsp;</strong></p>\n<div class=\"page\" title=\"Page 833\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>This is because, <strong>immediately</strong> after a <strong>mixed meal</strong> (containing carbohydrates, protein, and fat), carbohydrates is the most commonly metabolized component, so the<strong> RQ reaches 1</strong>. But, a few hours after, the body would have used up the readily available carbohydrates, and the RQ reaches 0.70, due to fat metabolism.</p>\n</div>\n</div>\n</div>\n</div>\n<p>The respiratory quotient is the&nbsp;<strong>ratio&nbsp;</strong>of<strong>&nbsp;carbon dioxide produced</strong>/<strong>oxygen consumed.&nbsp;</strong>The<strong>&nbsp;respiratory quotient&nbsp;</strong>for various substances:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Substance</strong></td>\n<td><strong>RQ</strong></td>\n</tr>\n<tr>\n<td>Carbohydrate</td>\n<td>1.00&nbsp;</td>\n</tr>\n<tr>\n<td>Protein (option D)</td>\n<td>0.81&nbsp;</td>\n</tr>\n<tr>\n<td>Fat (option B)</td>\n<td>0.71&nbsp;&nbsp;</td>\n</tr>\n<tr>\n<td>Alcohol (option C)</td>\n<td>0.66&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>In diabetes, the rate of utilization of carbohydrates reduces in relation to fats, hence RQ falls (approximately 0.7). The RQ is lowest when ketosis is very active.</p>\n<p>Note: For all metabolic fuels, the <strong>energy</strong> produced is the same (<strong>20 kJ/L of oxygen</strong>).</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "FC0240",
      "difficulty": "hard"
    },
    {
      "text": "An infant was brought with failure to thrive. On examination, the infant appears floppy with an enlarged tongue, hypotonia, skeletal muscle weakness, and hepatomegaly. The chest X-ray is shown below. Laboratory investigations reveal elevated levels of serum creatine kinase (CK), aspartate transaminase (AST), alanine transaminase (ALT), lactate dehydrogenase (LDH), and urine glucose tetrasaccharide. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Von Gierke disease"
        },
        {
          "id": 2,
          "text": "Pompe disease"
        },
        {
          "id": 3,
          "text": "Mc Ardle disease"
        },
        {
          "id": 4,
          "text": "Tarui disease"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>From the above-given clinical scenario and the radiograph showing <strong>cardiomegaly, </strong><strong>Pompe's disease</strong> is the most likely diagnosis.</p>\n<p><strong>Pompe's disease </strong>(Type 2 glycogen storage disease) is an autosomal recessive disorder that occurs due to <strong>α-1,4-glucosidase (acid maltase)</strong> deficiencyleading to lysosomal glycogen accumulation in cardiac, skeletal, and smooth muscle cells. It can appear within <strong>weeks or months</strong> after birth (infantile Pompe disease) or may appear late in juvenile, childhood, or adulthood disease (late-onset Pompe disease).</p>\n<p>The clinical symptoms of Pompe disease are <strong>hypotonia </strong>(floppy infant),<strong> skeletal muscle weakness, hepatomegaly, hypertrophic cardiomyopathy,</strong> macroglossia, and chest X-ray image shows<strong> cardiomegaly</strong>. </p>\n<p>Laboratory findings will show elevated levels of serum creatine kinase (CK), aspartate transaminase (AST), alanine transaminase (ALT), and lactate dehydrogenase (LDH). <strong>Urine glucose tetrasaccharide,</strong> a glycogen breakdown metabolite, is a reliable biomarker for disease severity and treatment response.</p>\n<p>Muscle biopsy shows the presence of vacuoles that stain positively for <strong>glycogen. </strong>It is diagnosed by detecting the decreased activity of the enzyme, <strong>α-1,4-glucosidase</strong> in the dried blood spots, leukocytes, blood mononuclear cells, muscle, or cultured skin fibroblasts.</p>\n<p>Other options:</p>\n<div class=\"page\" title=\"Page 3442\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Option A: <strong>Von Gierke disease </strong>occurs due to a deficiency of <strong>glucose-6-phosphatase.</strong> Patients present commonly in 3-4 months of age with <strong>hypoglycemia, lactic acidosis,</strong> hepatomegaly, growth retardation, hyperuricemia, and hyperlipidemia.</p>\n<p>Option C: <strong>McArdle disease</strong> occurs due to <strong>myophosphorylase</strong> deficiency leading to reduced ATP generation. The typical manifestations are myoglobinuria (secondary to rhabdomyolysis), muscle pain and cramps after heavy exercise. This pain may reduce after a brief period of rest and the patient may be able to perform an exercise. This is called the <strong>second wind phenomenon</strong>. Cardiomyopathy is not seen in this condition.</p>\n<p>Option D: <strong>Tarui disease</strong> (Type VII glycogen storage disorder)<strong> </strong>occurs due to the deficiency of muscle <strong>phosphofructokinase.</strong> The main clinical features are exercise intolerance, cramps, <strong>hemolytic anemia,</strong> and myoglobinuria. There is no hypertrophic cardiomyopathy.</p>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Glycogen Storage Diseases</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/782e85c36f0648698a222dca988adfabx1280x1863.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td>\n<p><strong>Enzyme deficiency</strong></p>\n</td>\n<td>\n<p><strong>Symptoms</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type 0</p>\n</td>\n<td>\n<p>Glycogen synthase</p>\n</td>\n<td>\n<p>Hypoglycemia</p>\n<p>Early death</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type Ia</p>\n<p>Von Gierke's disease</p>\n</td>\n<td>\n<p>Glucose-6- phosphatase</p>\n</td>\n<td>\n<p>Hepatomegaly and renomegaly&nbsp;due to glycogen accumulation</p>\n<p>Severe fasting hypoglycemia</p>\n<p>Growth failure</p>\n<p>Lactic acidosis</p>\n<p>Hyperuricemia</p>\n<p>Hyperlipidemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type Ib</p>\n</td>\n<td>\n<p>Endoplasmic reticulum glucose-6- phosphate transporter</p>\n</td>\n<td>\n<p>Same as Von Gierke's disease</p>\n<p>Recurrent infections due to impaired neutrophil function</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type II</p>\n<p>Pompe's disease</p>\n</td>\n<td>\n<p>Lysosomal &alpha;1,4:1,6 glucosidase</p>\n<p>(Acid maltase)</p>\n</td>\n<td>\n<p>Muscle weakness</p>\n<p>Death by age ~2 years (infantile variant)</p>\n<p>Cardiomegaly and heart failure</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type III</p>\n<p>Cori's/Forbe's disease</p>\n<p>(Limit dextrinosis)</p>\n</td>\n<td>\n<p>Glycogen debranching enzyme</p>\n</td>\n<td>\n<p>Muscle weakness</p>\n<p>Fasting hypoglycemia</p>\n<p>Hepatomegaly due to accumulation of branched chain polysaccharide (limit dextrins)</p>\n<p>Growth retardation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type IV</p>\n<p>Andersen disease</p>\n</td>\n<td>\n<p>Glycogen branching enzyme</p>\n</td>\n<td>\n<p>Failure to thrive</p>\n<p>Hepatomegaly due to accumulation of polysaccharide with few branch points</p>\n<p>Death at age ~5 years</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type V</p>\n<p>McArdle disease</p>\n</td>\n<td>\n<p>Muscle glycogen phosphorylase</p>\n</td>\n<td>\n<p>Exercise-induced cramps</p>\n<p>Renal failure due to rhabdomyolysis and myoglobinuria</p>\n<p>Second wind phenomenon</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type VI</p>\n<p>Her's disease</p>\n</td>\n<td>\n<p>Liver glycogen phosphorylase</p>\n</td>\n<td>\n<p>Generally benign</p>\n<p>Mild hypoglycemia</p>\n<p>Hepatomegaly</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type VII</p>\n<p>Tarui's disease</p>\n</td>\n<td>\n<p>Muscle phosphofructokinase</p>\n</td>\n<td>\n<p>Exercise-induced muscle cramps and weakness</p>\n<p>Growth retardation</p>\n<p>Hemolytic anemia</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/c1266082194e4afea9fa5e2630bf0a43.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "FC0235",
      "difficulty": "medium"
    },
    {
      "text": "A man presented with slurred speech and festinating shuffling gait. He tells that a course of levodopa was advised by his previous doctor but didn't show any effect. Which of the following mineral toxicity/ deficiency causes such features?",
      "choices": [
        {
          "id": 1,
          "text": "Selenium"
        },
        {
          "id": 2,
          "text": "Zinc"
        },
        {
          "id": 3,
          "text": "Manganese"
        },
        {
          "id": 4,
          "text": "Magnesium"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Manganese</strong> toxicity can cause&nbsp;<strong>secondary parkinsonism&nbsp;</strong>with features similar to atypical parkinsonism.</p>\n<div class=\"page\" title=\"Page 3430\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Secondary parkinsonism</strong> is characterized by Parkinson-like disease caused by agents/factors that cause <strong>basal ganglia dysfunction</strong>. These factors include drugs (tetrabenazine, metoclopramide, neuroleptics, flunarizine), stroke, tumor, infection, or toxins.&nbsp;Clinical features will be based on the region of the basal ganglia that has been damaged.</p>\n<p>Toxins such as carbon monoxide or manganese produce<strong>&nbsp;damage to the globus pallidus</strong>, and hence present with features resembling<strong>&nbsp;atypical parkinsonism&nbsp;</strong>such as:</p>\n</div>\n</div>\n</div>\n<ul>\n<li>Early speech and gait impairment</li>\n<li>Repeated early falls</li>\n<li><strong>Absence of rest tremor</strong></li>\n<li><strong>No motor asymmetry</strong></li>\n<li><strong>Poor or no response to levodopa</strong></li>\n<li>Aggressive clinical course</li>\n<li>Symptoms of severe early autonomic involvement</li>\n</ul>\n<div class=\"page\" title=\"Page 3430\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Manganese</strong>&nbsp;deficiency on the other hand can result in poor growth,&nbsp;bone demineralization, ataxia, convulsions, and abnormalities in carbohydrate and lipid metabolism.</p>\n<p>Other options</p>\n</div>\n</div>\n</div>\n<p>Option A:<strong> Selenium deficiency</strong> causes <strong>Keshan disease</strong> (cardiomyopathy in endemic regions of China); Excess selenium intake leads to <strong>selenosis&nbsp;</strong>(with hair loss, brittle nails, garlic breath odor, myopathy, and neurologic symptoms).</p>\n<p>Option B: <strong>Zinc toxicity</strong> leads to nausea, vomiting, headache, fever, and hypersalivation. <strong>Zinc deficiency</strong> causes dwarfism, hypogonadism, hypopigmented hair, hypogeusia, and impaired immunity.</p>\n<p>Option D: <strong>Hypomagnesemia</strong> is characterized by neurologic symptoms like tremors, muscle weakness, ataxia, delirium, and psychosis. <strong>Hypermagnesemia</strong> causes lethargy, weakness, hypotonia, weak tendon reflexes, and coma.</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "FC0242",
      "difficulty": "hard"
    },
    {
      "text": "A 20-year-old bodybuilder presented with fatigue on moderate exercise. He had recently started eating raw eggs for protein. Which of the following enzymes is likely deficient in him?",
      "choices": [
        {
          "id": 1,
          "text": "Glucose-6-phosphatase"
        },
        {
          "id": 2,
          "text": "Glycogen phosphorylase"
        },
        {
          "id": 3,
          "text": "Pyruvate carboxylase"
        },
        {
          "id": 4,
          "text": "Phosphoenolpyruvate carboxykinase"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The patient developed <strong>pyruvate carboxylase</strong> enzyme <strong>deficiency.</strong></p>\n<p>Individuals who eat an excess of <strong>uncooked</strong> <strong>egg-white,</strong> develop <strong>biotin deficiency</strong> and as a result deficiency of the carboxylase enzymes. This is because a protein called, <strong>avidin</strong> present in the egg-white <strong>binds to biotin</strong> in the diet, and makes biotin unavailable for intestinal absorption.</p>\n<p>Biotin deficiency can cause:</p>\n<ul>\n<li>Dermatitis</li>\n<li>Mental status changes (depression, hallucinations)</li>\n<li>Paraesthesia</li>\n<li>Alopecia</li>\n</ul>\n<p>Biotin serves as a co-enzyme for the synthesis of several carboxylase enzymes such as:</p>\n<ul>\n<li>Acetyl-CoA carboxylase</li>\n<li>Pyruvate carboxylase</li>\n<li>Propionyl CoA carboxylase</li>\n<li>Methylcrotonyl-CoA carboxylase</li>\n</ul><hr><h3>Related Pearl: Vitamin Deficiency States (Water-soluble Vitamins)</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Vitamin</strong></p>\n</td>\n<td>\n<p><strong>Deficiency State</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Thiamine (<strong>B<sub>1</sub></strong>)</p>\n</td>\n<td>\n<p><strong>Beriberi</strong></p>\n<p>Wernicke&ndash;Korsakoff&rsquo;s syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Riboflavin (<strong>B<span>2</span></strong>)</p>\n</td>\n<td>\n<p>Cheilosis, Magenta-coloured tongue,&nbsp;</p>\n<p>Glossitis, Seborrheic dermatitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Niacin (<strong>B<span>3</span></strong>)</p>\n</td>\n<td>\n<p><strong>Pellagra</strong></p>\n<p>Dermatitis, Diarrhea, Dementia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pantothenic acid (<strong>B<span>5</span></strong>)</p>\n</td>\n<td>\n<p><strong>Burning foot syndrome</strong> (historically called as \"Nutritional melalgia\")</p>\n<div class=\"page\" title=\"Page 90\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Dermatitis, enteritis, alopecia, ataxia</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pyridoxine (<strong>B<span>6</span></strong>)</p>\n</td>\n<td>\n<p>Microcytic anemia, convulsions, depression</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Biotin (<strong>B<span>7</span></strong>)</p>\n</td>\n<td>\n<p>Relatively unknown</p>\n<p>Dermatitis, atrophic glossitis, alopecia, paraesthesia, muscle pain, anorexia, hallucinations</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Folic acid (<strong>B<span>9</span></strong>)</p>\n</td>\n<td>\n<p>Megaloblastic anemia, neuropathy, neural tube defects, atrophic glossitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cobalamin (<strong>B<span>12</span></strong>)</p>\n</td>\n<td>\n<p>Pernicious anemia, dementia, spinal cord degeneration, homocysteinemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ascorbic acid (<strong>C</strong>)</p>\n</td>\n<td>\n<p><strong>Scurvy</strong></p>\n<p>Ecchymosis, bleeding gums, poor wound healing, fatigue, joint effusion, Scorbutic rosary</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "FC0233",
      "difficulty": "medium"
    },
    {
      "text": "Match the type of collagen with its associated disease entity.<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td><strong>Types of collagen</strong></td>\n<td><strong>Collagen defect disorders</strong></td>\n</tr>\n<tr>\n<td>1. Type I</td>\n<td>\n<p><span data-preserver-spaces=\"true\">A. Stickler syndrome</span></p>\n</td>\n</tr>\n<tr>\n<td>2. Type II</td>\n<td><span data-preserver-spaces=\"true\">B. Alport syndrome</span></td>\n</tr>\n<tr>\n<td>3. Type III</td>\n<td><span data-preserver-spaces=\"true\">C. Ehler Danlos syndrome (vascular subtype)</span></td>\n</tr>\n<tr>\n<td>4. Type IV</td>\n<td><span data-preserver-spaces=\"true\">D. Osteogenesis imperfecta</span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "1-D, 2-A, 3-B, 4-C"
        },
        {
          "id": 2,
          "text": "1-D, 2-A, 3-C, 4-B"
        },
        {
          "id": 3,
          "text": "1-C, 2-B, 3-A, 4-D"
        },
        {
          "id": 4,
          "text": "1-C, 2-B, 3-D, 4-A"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The correctly matched&nbsp;type of collagen with its associated disease entity is&nbsp;<strong>1-D, 2-A, 3-C, 4-B</strong>.&nbsp;</p>\n<div class=\"page\" title=\"Page 620\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Collagen</strong> is the most abundant protein and approximately 28 types have been isolated. The structure of collagen is a <strong>triple helix</strong> composed of 3 polypeptide chains having <strong>glycine</strong> residues at every third position.</p>\n<p><span>Genetic defects in the various types of collagen found predominantly at specific sites lead to various diseases summarized in the table below.</span></p>\n</div>\n</div>\n</div>\n</div>\n<table>\n<tbody>\n<tr>\n<td>Type of Collagen</td>\n<td>Distribution</td>\n<td>Defect</td>\n</tr>\n<tr>\n<td>Type I</td>\n<td>\n<div class=\"page\" title=\"Page 604\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Noncartilaginous connective tissues, including bone, tendon, skin</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>Osteogenesis imperfecta</td>\n</tr>\n<tr>\n<td>Type II</td>\n<td>\n<div class=\"page\" title=\"Page 604\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Cartilage, vitreous humor</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>Stickler syndrome</td>\n</tr>\n<tr>\n<td>Type III</td>\n<td>\n<div class=\"page\" title=\"Page 604\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Extensible connective tissues, including skin, lung, and vascular system</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<p>Ehler Danos syndrome (Vascular sub-type)</p>\n</td>\n</tr>\n<tr>\n<td>Type IV</td>\n<td>&nbsp;\n<div class=\"page\" title=\"Page 604\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Basement membranes</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>Alport syndrome</td>\n</tr>\n<tr>\n<td>Type VII</td>\n<td>&nbsp;\n<div class=\"page\" title=\"Page 604\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Dermal-epidermal junction</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>Epidermolysis bullosa aquisita</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<div class=\"page\" title=\"Page 3016\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>&nbsp;</p>\n<p>In <strong>osteogenesis imperfecta</strong>, there is a severe decrease in bone mass that makes bones brittle, associated with blue sclerae, dental abnormalities, progressive hearing loss, and positive family history.</p>\n<p><strong>Stickler syndrome</strong> is characterized by skeletal changes, orofacial abnormalities, and auditory abnormalities.</p>\n<p>In <strong>Ehler Danlos syndrome</strong> ( vascular subtype ) there are features of classic EDS ( skin and joint involvement ) as well as severe muscular hypotonia after birth, progressive kyphoscoliosis, osteopenia, occasional rupture of the eye globe, and great arteries.</p>\n<div class=\"page\" title=\"Page 3019\"><strong>Alport syndrome</strong> is characterized by the presence of a genetically abnormal basement membrane giving rise to proteinuria and hematuria.</div>\n</div>\n</div>\n</div>\n</div>\n<p>&nbsp;</p><hr><h3>Related Pearl: Types of Collagen</h3><table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Collagen Subtypes&nbsp;</strong></td>\n</tr>\n<tr>\n<td><strong>Type 1</strong></td>\n<td><strong>Location&nbsp;</strong>\n<ul>\n<li>Dermis&nbsp;</li>\n<li>Bone&nbsp;</li>\n<li>Tendons&nbsp;</li>\n<li>Ligaments</li>\n<li>Dentin</li>\n<li>Cornea</li>\n<li>Blood Vessels&nbsp;</li>\n<li>Scar tissue&nbsp;</li>\n</ul>\n<p><strong>Associated disease&nbsp;</strong></p>\n<ul>\n<li>Osteogenesis Imperfecta</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Type 2</strong></td>\n<td>\n<p><strong>Location&nbsp;</strong></p>\n<ul>\n<li>Cartilage&nbsp;</li>\n<li>Vitreous humor&nbsp;</li>\n<li>Nucleus pulposus</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Type 3</strong></td>\n<td>\n<p><strong>Location&nbsp;</strong></p>\n<ul>\n<li>Skin&nbsp;</li>\n<li>Lung&nbsp;</li>\n<li>Intestines&nbsp;</li>\n<li>Blood Vessels&nbsp;</li>\n<li>Bone marrow&nbsp;</li>\n<li>Lymphatics&nbsp;</li>\n<li>Granulation tissue</li>\n</ul>\n<p><strong>Associated disease&nbsp;</strong></p>\n<ul>\n<li>Ehler-Danlos syndrome&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Type 4</strong></td>\n<td>\n<p><strong>Location&nbsp;</strong></p>\n<ul>\n<li>Basement membrane&nbsp;</li>\n</ul>\n<p><strong>Associated diseases&nbsp;</strong></p>\n<ul>\n<li>Alport syndrome</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "FC0251",
      "difficulty": "medium"
    },
    {
      "text": "A 20-year-old female patient presents with the following finding as shown in the image below. On further investigation, she is found to have reduced levels of the enzyme UDP-glucuronosyltransferase. Which of the following disorders is she most likely suffering from?",
      "choices": [
        {
          "id": 1,
          "text": "Type I Crigler-Najjar syndrome"
        },
        {
          "id": 2,
          "text": "Gilbert syndrome"
        },
        {
          "id": 3,
          "text": "Dubin Johnson syndrome"
        },
        {
          "id": 4,
          "text": "Rotor syndrome"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>With the given clinical scenario and with reduced levels of enzyme UDP-glucuronosyltransferase, the patient is most likely suffering from <strong>Gilbert syndrome</strong>. <br /><br /><strong>Gilbert syndrome</strong> is an autosomal recessive condition characterized by <strong>decreased activity</strong> of the <strong>enzyme UDP-glucuronosyltransferase</strong>, which is responsible for the conjugation of bilirubin. This leads to <strong>unconjugated hyperbilirubinemia</strong>, that presents as yellowish discolouration of the sclera (icterus/jaundice) as seen in the given image.</p>\n<p>Individuals with Gilbert syndrome are usually <strong>asymptomatic</strong> except for <strong>intermittent episodes of jaundice</strong>, which usually occurs for the first time during <strong>adolescence</strong>, due to changes in the concentration of sex hormones. Some patients may have complaints like malaise, fatigue, nausea, anxiety, loss of appetite, and abdominal discomfort. Symptoms are usually precipitated by <strong>triggers</strong> such as fasting, intercurrent illness, menstruation, and dehydration.</p>\n<div class=\"page\" title=\"Page 2601\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Administration of <strong>phenobarbital</strong> shows normalisation of the serum bilirubin concentration and hepatic bilirubin clearance.</p>\n<p>Gilbert syndrome usually doesn't require any treatment.</p>\n</div>\n</div>\n</div>\n</div>\n<p>Other options:<br /><br />Option A: <strong>Type I Crigler-Najjar syndrome</strong> is characterized by a complete deficiency of the enzyme UDP-glucuronosyltransferase. It usually presents as severe congenital jaundice (serum bilirubin levels over 20 mg/dL) and accompanying brain damage.<br /><br />Options C and D: <strong>Dubin Johnson</strong> and <strong>Rotor syndrome</strong> both have elevated conjugated bilirubin in the blood, and are due to defective secretion of conjugated bilirubin into the bile.</p><hr><h3>Related Pearl: Hereditary Hyperbilirubinemias</h3><table>\n<tbody>\n<tr>\n<td><strong>Disorder</strong></td>\n<td><strong>Inheritance</strong></td>\n<td><strong>Defects in bilirubin metabolism</strong></td>\n<td><strong>Clinical course</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Unconjugated Hyperbilirubinemia</strong></p>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Crigler-Najjar syndrome type I</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>Absent UGT1A1 activity</p>\n</td>\n<td>\n<p>Fatal in the neonatal period</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Crigler-Najjar syndrome type II</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>Decreased UGT1A1 activity</p>\n</td>\n<td>\n<p>Generally mild,</p>\n<p>occasional kernicterus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Gilbert syndrome</p>\n</td>\n<td>\n<p>AR (common)</p>\n<p>AD (occasional)</p>\n</td>\n<td>\n<p>Decreased UGT1A1 activity</p>\n</td>\n<td>\n<p>Innocuous</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Conjugated Hyperbilirubinemia</strong></p>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Dubin-Johnson syndrome</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>Impaired biliary excretion of bilirubin glucuronides due to a mutation in canalicular multidrug resistance protein 2 (MRP2)</p>\n</td>\n<td>\n<p>Innocuous</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Rotor syndrome</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>Decreased hepatic uptake and storage</p>\n<p>Decreased biliary excretion</p>\n</td>\n<td>\n<p>Innocuous</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Hyperbilirubinemia- Causes</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;<strong>Predominantly Unconjugated Hyperbilirubinemia&nbsp;</strong></td>\n<td><strong>Conjugated hyperbilirubinemia</strong></td>\n</tr>\n<tr>\n<td>\n<p>Excess production of bilirubin</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Hemolytic anemias</p>\n</td>\n<td>\n<p>Biliary tract obstruction</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Resorption of blood from internal hemorrhage (e.g., alimentary tract bleeding, hematomas)</p>\n</td>\n<td>\n<p>&nbsp;Biliary tract diseases like primary biliary cirrhosis and primary sclerosing cholangitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ineffective erythropoiesis (e.g., pernicious anemia, thalassemia)</p>\n</td>\n<td>\n<p>Dubin Johnson syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Reduced hepatic uptake</p>\n</td>\n<td>\n<p>Rotor syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Drug interference with membrane carrier systems</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Some cases of Gilbert syndrome</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Impaired bilirubin conjugation</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Physiologic jaundice of the newborn (decreased UGT1A1 activity, decreased excretion)</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Breast milk jaundice (&beta;-glucuronidases in milk)</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Genetic deficiency of UGT1A1 activity (Crigler-Najjar syndrome types I and II)</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Gilbert syndrome</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Diffuse hepatocellular disease (e.g., viral or drug-induced hepatitis, cirrhosis)</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/239cf30b48884c9598691ba84680bb40.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "FC0236",
      "difficulty": "medium"
    },
    {
      "text": "A 7-year-old child is brought with a history of impaired vision and severe photophobia. On examination, he has light hair, light skin color, and pale blue eyes. A disorder due to deficiency in the enzyme tyrosinase is suspected. What is the likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Albinism"
        },
        {
          "id": 2,
          "text": "Tyrosinemia type 1"
        },
        {
          "id": 3,
          "text": "Tyrosinemia type 2"
        },
        {
          "id": 4,
          "text": "Homocystinuria"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><span data-preserver-spaces=\"true\">The clinical scenario along with the deficiency of the&nbsp;</span><span data-preserver-spaces=\"true\">enzyme&nbsp;</span><strong><span data-preserver-spaces=\"true\">tyrosinase&nbsp;</span></strong><span data-preserver-spaces=\"true\">point to the diagnosis of <strong>albinism</strong>.&nbsp;</span></p>\n<p><strong><span data-preserver-spaces=\"true\">Oculocutaneous albinism</span></strong><span data-preserver-spaces=\"true\">&nbsp;<strong>(OCA)</strong> is a group of inherited disorders characterized by a reduction or complete lack of <strong>melanin</strong> pigment in the <strong>skin, hair,</strong> and<strong> eyes</strong> leading to hypopigmentation.&nbsp;It is either due to defective melanosomes or defective protein involved in the formation and transfer of melanin. </span></p>\n<p><span data-preserver-spaces=\"true\">There are 7 types of&nbsp;nonsyndromic albinism (OCA1 to OCA7).<strong> OCA type 1</strong> is characterised by reduced or absent <strong>tyrosinase</strong> activity.&nbsp;</span><span data-preserver-spaces=\"true\">The<strong> first step</strong> in <strong>melanin synthesis</strong> involves the oxidation of L-tyrosine to DOPA by the enzyme tyrosinase.&nbsp;</span>Tyrosinase further acts on DOPA to form dopaquinone, which undergoes a series of reactions to form melanin.&nbsp;</p>\n<p><span data-preserver-spaces=\"true\">Clinical features include&nbsp;<strong>white hair,</strong>&nbsp;<strong>white skin, </strong>and&nbsp;<strong>iris</strong> appearing&nbsp;<strong>blue-grey</strong> in oblique light. Ocular manifestations include&nbsp;<strong>photophobia,</strong> nystagmus, and&nbsp;<strong>decreased visual acuity.&nbsp;</strong></span></p>\n<p><span data-preserver-spaces=\"true\">Other options-</span></p>\n<p>Option B- <strong>Tyrosinemia type 1</strong> is caused due to the deficiency of the enzyme <strong>fumarylacetoacetate hydrolase</strong>. Clinical findings include&nbsp;cirrhosis, liver failure, rickets, failure to thrive, peripheral neuropathy, and boiled cabbage odour.&nbsp;</p>\n<p>Option C- <strong>Tyrosinemia type 2</strong> is caused due to the deficiency of the enzyme <strong>tyrosine transaminase.</strong> Clinical findings include palmoplantar keratosis, painful corneal erosions with photophobia, and <strong>learning disability.&nbsp;</strong></p>\n<p>Option D- <strong>Homocystinuria</strong> is caused due to <strong>cystathionine beta-synthase</strong> deficiency. Clinical findings include lens dislocation, thrombotic vascular disease, <strong>intellectual</strong> <strong>disability</strong>, and osteoporosis.</p>\n<p>Given below is an image of a young child with OCA showing white hair, skin, and pale iris:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/36fbf01e9a85437596b312b2a4c032cex794x527.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Amino acid Enzymatic Disorders and the Associated Enzymes</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disorder</strong></p>\n</td>\n<td>\n<p><strong>Enzyme defect</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Phenylketonuria</p>\n</td>\n<td>\n<p>Phenylalanine hydroxylase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tyrosinosis (Tyrosinemia type I)</p>\n</td>\n<td>\n<p>Maleyl Acetate isomerase or Fumarylacetoacetate hydrolase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maple syrup urine disease&nbsp;</p>\n</td>\n<td>\n<p>Branched-chain alpha-keto acid dehydrogenase(BCKAD)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Alkaptonuria</p>\n</td>\n<td>\n<p>Homogentisate oxidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Albinism</p>\n</td>\n<td>\n<p>Tyrosinase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Homocystinuria type I</p>\n</td>\n<td>\n<p>Cystathionine synthase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Homocystinuria type II</p>\n</td>\n<td>\n<p>Defect in methylcobalamin formation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cystathioninuria</p>\n</td>\n<td>\n<p>Cystathionase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tyrosinemia type II or Richner-Hanhart syndrome</p>\n</td>\n<td>\n<p>Tyrosine transaminase or Tyrosine aminotransferase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Primary hyperoxaluria</p>\n</td>\n<td>\n<p>Alanine glyoxalate aminotransferase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypervalinemia</p>\n</td>\n<td>\n<p>Valine transaminase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Isovaleric acidemia</p>\n</td>\n<td>\n<p>Isovaleryl CoA dehydrogenase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Histidinemia</p>\n</td>\n<td>\n<p>Histidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hyperprolinemia type I</p>\n</td>\n<td>\n<p>Proline oxidase</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "FC0244",
      "difficulty": "medium"
    },
    {
      "text": "A middle-aged man who is a chronic alcoholic presented to the casualty with confusion, ataxia, and diplopia. What is the protocol to treat this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Vitamin B1 injection followed by glucose infusion"
        },
        {
          "id": 2,
          "text": "Glucose infusion followed thiamine injection"
        },
        {
          "id": 3,
          "text": "Glucose infusion alone"
        },
        {
          "id": 4,
          "text": "Thiamine infusion alone"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The above clinical history is suggestive of <strong>Wernicke's&nbsp;encephalopathy.&nbsp;</strong>The current standard of treatment for patients with symptoms of Wernicke's encephalopathy is to give<strong>&nbsp;thiamine 100 mg intravenously before</strong> administering<strong> glucose-containing</strong>&nbsp;IV<strong> fluids.</strong></p>\n<p>Thiamine deficiency&nbsp;leads to the following:</p>\n<ol>\n<li><strong>Wernicke&rsquo;s encephalopathy:&nbsp;</strong>It is more commonly seen in alcoholics with chronic thiamine deficiency. It is characterized by:\n<ul>\n<li>Global confusion</li>\n<li>Truncal ataxia</li>\n<li>Ophthalmoplegia</li>\n<li>Horizontal nystagmus&nbsp;</li>\n</ul>\n</li>\n<li><strong>Korsakoff psychosis:</strong>&nbsp;symptoms in addition to those of Wernicke's encephalopathy include:\n<ul>\n<li>Memory loss</li>\n<li><strong>Confabulation</strong></li>\n</ul>\n</li>\n<li><strong>Beriberi:&nbsp;</strong>It can present with:\n<ul>\n<li><strong>Dry</strong> beriberi: sensorimotor peripheral neuropathy, muscle weakness</li>\n<li><strong>Wet</strong> beriberi: tachycardia, cardiomegaly, high-output cardiac failure</li>\n</ul>\n</li>\n</ol><hr><h3>Related Pearl: Vitamin Deficiency States (Water-soluble Vitamins)</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Vitamin</strong></p>\n</td>\n<td>\n<p><strong>Deficiency State</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Thiamine (<strong>B<sub>1</sub></strong>)</p>\n</td>\n<td>\n<p><strong>Beriberi</strong></p>\n<p>Wernicke&ndash;Korsakoff&rsquo;s syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Riboflavin (<strong>B<span>2</span></strong>)</p>\n</td>\n<td>\n<p>Cheilosis, Magenta-coloured tongue,&nbsp;</p>\n<p>Glossitis, Seborrheic dermatitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Niacin (<strong>B<span>3</span></strong>)</p>\n</td>\n<td>\n<p><strong>Pellagra</strong></p>\n<p>Dermatitis, Diarrhea, Dementia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pantothenic acid (<strong>B<span>5</span></strong>)</p>\n</td>\n<td>\n<p><strong>Burning foot syndrome</strong> (historically called as \"Nutritional melalgia\")</p>\n<div class=\"page\" title=\"Page 90\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Dermatitis, enteritis, alopecia, ataxia</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pyridoxine (<strong>B<span>6</span></strong>)</p>\n</td>\n<td>\n<p>Microcytic anemia, convulsions, depression</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Biotin (<strong>B<span>7</span></strong>)</p>\n</td>\n<td>\n<p>Relatively unknown</p>\n<p>Dermatitis, atrophic glossitis, alopecia, paraesthesia, muscle pain, anorexia, hallucinations</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Folic acid (<strong>B<span>9</span></strong>)</p>\n</td>\n<td>\n<p>Megaloblastic anemia, neuropathy, neural tube defects, atrophic glossitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cobalamin (<strong>B<span>12</span></strong>)</p>\n</td>\n<td>\n<p>Pernicious anemia, dementia, spinal cord degeneration, homocysteinemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ascorbic acid (<strong>C</strong>)</p>\n</td>\n<td>\n<p><strong>Scurvy</strong></p>\n<p>Ecchymosis, bleeding gums, poor wound healing, fatigue, joint effusion, Scorbutic rosary</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "FC0243",
      "difficulty": "easy"
    },
    {
      "text": "A young man with chronic bacterial prostatitis was treated with cotrimoxazole. During treatment, he developed malaise, jaundice, abdominal pain, and dark urine. His blood picture is given below. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Hemolytic uremic syndrome"
        },
        {
          "id": 2,
          "text": "Autoimmune hemolytic anemia"
        },
        {
          "id": 3,
          "text": "Paroxysmal nocturnal hemoglobinuria"
        },
        {
          "id": 4,
          "text": "Glucose-6 phosphate dehydrogenase deficiency"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The most likely diagnosis in the above case scenario is glucose-6-phosphate dehydrogenase <strong>(G6PD) deficiency.</strong></p>\n<p>The clinical features are suggestive of an <strong>acute hemolytic reaction</strong> following the administration of <strong>cotrimoxazole</strong>. A hemolytic attack starts with abrupt onset of malaise, weakness, and abdominal or lumbar pain. After an interval of several hours to 2–3 days, the patient develops jaundice and often dark urine, due to hemoglobinuria. </p>\n<p>The peripheral smear shows characteristic <strong>\"bite cells\"</strong> or <strong>degmacytes</strong> or <strong>blister cells</strong>. In G6PD deficiency uncontrolled oxidative stress causes hemoglobin to denature and form Heinz bodies. Bite cells result from the <strong>removal of Heinz bodies</strong> by macrophages in the spleen.</p>\n<p>Cotrimoxazole contains <strong>sulfamethoxazole</strong> which triggers a <strong>hemolytic reaction</strong> in people with <strong>G6PD deficiency</strong>.</p>\n<p>Drugs that carry a risk of clinical hemolysis in persons with G6PD Deficiency:</p>\n<table>\n<tbody>\n<tr>\n<td>Antimalarials</td>\n<td>\n<p>Primaquine</p>\n<p><strong>Chloroquine</strong></p>\n<p>Dapsone/chlorproguanil</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Sulphonamides/</p>\n<p>sulphones</p>\n</td>\n<td>\n<p><strong>Sulfamethoxazole</strong></p>\n<p>Sulfasalazine</p>\n<p>Sulfisoxazole</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Antibacterial/</p>\n<p>antibiotics</p>\n</td>\n<td>\n<p><strong>Cotrimoxazole</strong></p>\n<p>Ciprofloxacin</p>\n<p>Chloramphenicol</p>\n<p>Nalidixic acid</p>\n<p>Norfloxacin</p>\n<p><strong>Nitrofurantoin</strong></p>\n</td>\n</tr>\n<tr>\n<td>Others</td>\n<td>\n<p>Naphthalene</p>\n<p><strong>Methylene blue</strong></p>\n<p>Rasburicase </p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/12a46f3301884114b2bdc91ab2005c81.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "FC0241",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following modifications occur posttranscriptionally to produce a mature eukaryotic mRNA?<div class='question-desc-html'><ol>\n<li>Capping</li>\n<li>Polyadenylation</li>\n<li>Phosphorylation</li>\n<li>Trimming</li>\n<li>Splicing</li>\n<li>Hydroxylation</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 2, 4"
        },
        {
          "id": 2,
          "text": "1, 2, 5"
        },
        {
          "id": 3,
          "text": "3, 4, 6"
        },
        {
          "id": 4,
          "text": "3, 5, 6"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Capping</strong>,&nbsp;<strong>polyadenylation</strong>, and&nbsp;<strong>splicing&nbsp;</strong>are the modifications that occur <strong>posttranscriptionally</strong> to produce a mature eukaryotic mRNA.&nbsp;<strong>Phosphorylation</strong>,&nbsp;<strong>hydroxylation</strong>, and&nbsp;<strong>trimming&nbsp;</strong>are modifications that occur&nbsp;<strong>posttranslationally</strong>.</p>\n<p>A mature eukaryotic mRNA is formed after the pre-mRNA components of the heterogenous nuclear RNA (hnRNA) undergo the following posttranscriptional modifications in the nucleus:</p>\n<ol>\n<li><strong>Addition of a 5&prime; cap</strong>: A 7-methylguanosine is attached to the 5&prime; terminal end of the mRNA via a 5&prime;-to-5&prime; triphosphate linkage. This stabilizes the mRNA and allows initiation of translation.</li>\n<li><strong>Addition of a 3&prime;-poly-A tail</strong>: The poly-A tail is added by the nuclear enzyme, polyadenylate polymerase, after clevage of the polyadenylation signal sequence (AAUAAA) found near the 3&prime; end of the mRNA. This terminates eukaryotic transcription. Furthermore, it stabilizes the mRNA, allows it to exit from the nucleus, and helps in translation.</li>\n<li><strong>Splicing</strong>: This is the process of removing introns (intervening sequences that do not code for proteins) and joining exons (the coding or expressed sequences), carried out by the spliceosome. Alternative splicing occurs in different tissues to produce varied number of proteins from a limited set of genes.</li>\n</ol>\n<table>\n<tbody>\n<tr>\n<td>\n<p>Protein coding RNA</p>\n</td>\n<td>\n<p>Non Protein coding RNA</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>mRNA</p>\n</td>\n<td>\n<p>Ribosomal RNAs (rRNA)</p>\n<p>Long noncoding RNAs (lncRNAs)</p>\n<p>Transfer RNAs (tRNA)</p>\n<p>Small nuclear RNAs (snRNAs)</p>\n<p>Micro and silencing RNAs (miRNAs and siRNAs)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "FC0250",
      "difficulty": "medium"
    },
    {
      "text": "A patient comes to you with vitamin D deficiency. You advise the patient to take a walk under sufficient sunlight everyday. What is the correct sequence of products formed during vitamin D synthesis?<div class='question-desc-html'><ol>\n<li>7-dehydrocholesterol</li>\n<li>Cholecalciferol</li>\n<li>25-hydroxycholecalciferol</li>\n<li>1,25-dihydroxycholecalciferol</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "4-3-2-1"
        },
        {
          "id": 2,
          "text": "1-2-3-4"
        },
        {
          "id": 3,
          "text": "1-3-2-4"
        },
        {
          "id": 4,
          "text": "1-4-3-2"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The correct sequence of products formed during vitamin D synthesis is <strong>1-2-3-4</strong>.</p>\n<p>Vitamin D is obtained by synthesis in the skin with adequate sunlight exposure or dietary supplementation. It helps in regulating calcium absorption and homeostasis. Deficiency results in rickets in children and osteomalacia in adults and is a common problem in areas with inadequate sunlight.</p>\n<p>The sequence of vitamin D synthesis is:</p>\n<ol>\n<li><strong>Skin</strong>: <strong>7-dehydrocholesterol</strong> is nonenzymatically converted to <strong>previtamin D</strong> on exposure to ultraviolet light. It is converted to <strong>cholecalciferol</strong>, which then enters the bloodstream.</li>\n<li><strong>Liver</strong>: Cholecalciferol is hydroxylated to form <strong>25-hydroxyvitamin D </strong>(calcidiol), which is bound to a vitamin D-binding globulin and released into the bloodstream. This is the <strong>main storage form</strong> of vitamin D. </li>\n<li><strong>Kidney</strong>:<strong> </strong><strong>25-hydroxyvitamin D </strong>is further hydroxylated to form <strong>1,25 dihydroxyvitamin D</strong> (calcitriol). This is the <strong>biologically active form</strong> of vitamin D. In some cases, it can also undergo 24-hydroxylation to form an inactive metabolite called 24,25-dihydroxyvitamin D.</li>\n</ol>\n<p>The steps of vitamin D synthesis are summarized below.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/fde3485fa4914eaeae335f36ce978ac3x1280x1630.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Fat-soluble vitamins</h3><table>\n<tbody>\n<tr>\n<td rowspan=\"2\"><strong>Vitamin</strong></td>\n<td rowspan=\"2\"><strong>Active form</strong></td>\n<td rowspan=\"2\"><strong>Deficiency</strong></td>\n<td rowspan=\"2\"><strong>Toxicity</strong></td>\n<td colspan=\"3\"><strong>Required daily allowance</strong></td>\n</tr>\n<tr>\n<td>Children</td>\n<td>Male</td>\n<td>Female</td>\n</tr>\n<tr>\n<td>Vitamin A</td>\n<td>\n<p>Retinol</p>\n<p>Retinal</p>\n<p>Retinoic acid</p>\n</td>\n<td>\n<p>Night blindness, xerophthalmia,</p>\n<p>Acne, psoriasis,</p>\n<p>Impaired immunity</p>\n</td>\n<td>\n<p>Affects lysosomes</p>\n<p>Acute- pseudotumor cerebrii, exfoliative dermatitis</p>\n<p>Chronic-fractures</p>\n</td>\n<td>\n<p>390-630mcg (1-9 years)</p>\n<p>770-1000mcg (10-18 years)</p>\n</td>\n<td>1000mcg&nbsp;</td>\n<td>&nbsp;\n<p>Adult - 840mcg</p>\n<p>Pregnancy - 900mcg</p>\n<p>Lactation - 950 mcg</p>\n</td>\n</tr>\n<tr>\n<td>Vitamin D</td>\n<td>1,25-Dihydro-cholecalciferol</td>\n<td>\n<p>Children- Rickets</p>\n<p>Adults-osteomalacia</p>\n</td>\n<td>Calcinosis</td>\n<td>&nbsp;\n<p>400 IU (&lt;1 year)</p>\n<p>600 IU (&gt;1 year)</p>\n</td>\n<td>&nbsp;600 IU</td>\n<td>\n<p>Adult - 600 IU</p>\n<p>Pregnancy - 600 IU</p>\n<p>Lactation - 600 IU</p>\n</td>\n</tr>\n<tr>\n<td>Vitamin E</td>\n<td>&alpha;-tocopherol</td>\n<td>\n<p>Hemolytic anemia,</p>\n<p>axonal degeneration,</p>\n<p>spinocerebellar ataxia</p>\n</td>\n<td>\n<p>Reduced platelet aggregation,&nbsp;</p>\n<p>Interferes with vitamin K</p>\n</td>\n<td>&nbsp;5-8 mg</td>\n<td>&nbsp;10 mg</td>\n<td>\n<p>Adult - 8 mg</p>\n<p>Pregnancy - 10 mg</p>\n<p>Lactation - 12 mg</p>\n</td>\n</tr>\n<tr>\n<td>Vitamin K</td>\n<td>\n<p>Menedione</p>\n<p>Menoquinone</p>\n<p>Phyloquinone</p>\n</td>\n<td>\n<p>Elevated prothrombin time and bleeding</p>\n<p>Haemorrhagic disease of newborn</p>\n</td>\n<td>\n<p>Hemolysis</p>\n<p>Hyperbilirubinemia</p>\n<p>Kernicterus</p>\n</td>\n<td>\n<p>&lt;1 year - 2-3&nbsp;&micro;g</p>\n<p>Children - 30-50&nbsp;&micro;g</p>\n&nbsp;</td>\n<td>55 &micro;g&nbsp;</td>\n<td>55 &micro;g&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Note:The <strong>RDA</strong> for <strong>Vitamin D</strong> in the <strong>elderly</strong> (&gt;60 years) is <strong>800 IU</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "FC0252",
      "difficulty": "medium"
    }
  ]
}